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1. INTRODUCTION 
Siddha  system is a unique system of medicine because it is both spiritually 
and mentally enriched. Siddha system is one of the ancient system of Indian medicine. 
It evolved in south india and siddha medicine was developed by siddhars. 
Prehistoric medicines incorporated plants (herbalism), animal part and 
minerals. In many cases these materials were used spiritually as magical substances 
by priests, shamans,or medicine men. 
           Our human body consist of 96 thathuvam,72000 nadi narampugal, 7 udal 
thathukkal, 3 uyir thathukkal and imbalance in these constituents leads to rogum. 
The normal functioning of human body is based on homeostasis of 3 forces or 
3 humors called VATHAM, PITHAM and KABAM. 
Any derangements in this homeostasis lead to pathological condition called 
PINI or NOI 
Siddhars classified the diseases in to 4448 types. Among that vadha disease 
are classified in to 84 types mentioned in yugi vadhiya cinthamani.In which uthira 
vatha suronidham is one among them and signs and symptoms of this disease is 
correlated with Rheumatoid arthritis in morden science. 
  Siddhars diagnosing the diseases by means of envagai thervu, nadi, and 
neerkuri, neikuri are the Precise diagnostic stool of siddhars. The treatment aspect 
involve the neutralization of affected humour. 
             A siddha physiciant kneely observe the naadi before starting any treatment. 
Hence unlike other system of medicines there does not exist only a symptomatic 
treatment in siddha.  A strong relationship develops between the patients and 
physician. The physiciant not only heal the disease of the patient through medicines 
but also provide an assurance it his mind and prayer for the soul.  Hence siddha 
system is unique when compared to any other system of medicine as it is both 
medicinally and spiritually enriched. 
            Now the merits and the advantages of siddha medical system is flourishing 
and awareness of  siddha is progressing worldwide. 
  By  giving purgatives, vatha kutram is neutralized. By giving emetics, pitha 
kutram is neutralized. By giving nasiyam kapha kutram is neutralized  
RHEUMATOID ARTHRITIS is an autoimmune disorder which is world wide 
in distribution. About 0.5 - 3% seems to be affected. Women are affected 3 times 
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more than men. It is present from early childhood (when it is rare) to late old age, 
most common in 30-50 years. 
  It is the disease which causes much distress to the humanity at large. Till now 
there is no definite cure for this disease. Due to the prolonged and uncertain course of 
the disease and its prevalance the author planned to be conduct the study  on 
UTHIRAVATHA SURONITHAM. 
 
The author’s choice of drug for clinical study were, 
1. KEEL VAYU NIVARANA CHOORANAM- 10-20 gm twise a day internally 
[The pharmacopoeia of siddha research 
medicine. Page no 98] 
2. VATHATHIRKU THYLAM  - externally  
 [Theraiyar vagadam.Page no 83] 
3. VEDHU- external theraphy  
     [Aruvaimaruthuvam. [page.no 40-41] 
4. The drug were prepared by the author and tried in 40caese in the OPD                  
and IPD. 
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2. AIM AND OBJECTIVE 
AIM: 
 Phase II Clinical Observation criteria based study of “Uthiravatha 
Suronitham” and the drug choice “KEELVAYU NIVARANA CHOORANAM” 
(Internal) and “VATHATHIRKU HYLAM”(External) medicine. 
 
OBJECTIVES 
Primary objective 
To evaluate the clinical efficacy of “KEELVAYU NIVARANA 
CHOORANAM ” (internal) & “VATHATHIRKU THYLAM” (external) in 
reducing the pain and restricted joint movements in the treatment of ‘Uthiravatha 
suronitham” (rheumatoid arthritis).  
 
Secondary objective 
• To study the effect of Vedhu (steam bath) in reducing the pain towards the 
efficacy of medicine.  
• To conduct a clinical trail with a well defined proforma on identified patients 
with “UTHIRAVATHA SURONITHAM”. 
• To correlate the etiology, clinical features, signs and symptoms of 
“UTHIRAVATHA SURONITHAM” in siddha system to Rheumatoid 
Arthritis in modern science. 
• To study “UTHIRAVATHA SURONITHAM” on the basis of Mukkutram, 
poripulangal, udalkattugal, envagai thervugal in order to evaluate the 
pathology.  
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3. REVIEW OF LITERATURE 
SIDDHA ASPECT 
PRINCIPLES OF SIDDHA 
            Siddhars have recommended certain basic guidelines to be followed for 
healthy living which includes following certain regimen as mentioned in” PINI 
ANUGA VIDHI”  that help prevent disease. The rules are given below 
1.Drinking boiled water 
2.Take meals twice a day 
3.Take diluted buttermilk and melted ghee 
4.Take sufficient quantity of milk and milk products 
5. Never eat root tubers except yam 
6.Never consume food that was prepared the previous day 
7.Always have food after feeling hungry 
8.Always consume sour curd 
9.Drink water at the end of meals 
10.Practice walking after a good diet 
11.Use hot water while taking oil bath 
12. Take snuff medications eight times in a year 
13. Take purgative medication every four months in a year 
14. Take emetic medication once in six months  
15.Never sleep during day time  
16. Never suppress any natural urge 
17.Always indulge in healthy sexual acts 
18.Never sleep under a tree shade  
19. Never smell fragrance during midnight 
20. Never resides close to the dust 
21.Apply eye medications once in three days 
22.Shave weekly once  
23. Take oil bath once in every 4 days 
  
  
5 
 
The siddha system is said to be the human body is composed of 5 elements such as : 
1. EARTH- gives shape to the body and release site energy.Bones, muscle,and 
tissues if in the body 
2. WATER-Makes earth supple and transmission of energy.Serum, 
lymph,saliva,etc., represent in the body. 
3. FIRE- Makes the form of the body steady and gives vigour and stimulation. 
Digestion and circulation represent in the body. 
4. AIR- Ignites the fire works as a life carrier and is the support of all contact and 
exchange respiration and Nervous system represent in the body 
5. ETHER- It is the creator of life itself in the body. 
  A harmonious combination and function of these five elements in the body 
produce a healthy and beautiful life. 
 
Characteristic features of Vatha diseases 
1. Body ache 
2. Nerve weakness 
3. Dryness 
4. Joint pain 
5. Bony pricking pain 
6. Constipation 
7. Darkness of eyes,skin and urine 
8. Mental distress 
9. Difficulty  to movement of limbs 
10. Polydypsia 
 
QUALITIES OF VATHAM 
The normal qualities are 
1.Rough  
2.Dry 
3.Light 
4.Cold 
5.Movable 
6.Subtle 
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Opposite qualities of vatham 
1. Soft 
2. Untuous 
3. Heavy 
4. Hot 
5. Stable 
6. Solid 
7. Relation with taste 
 
    CAUSES OF VATHA DISEASES 
“gfuNt thjkJ Nfhgpj; jg;Ngh; ;; ;; ;  
 gz;ghf ngz;Nghf kJjhd; nra;apy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 efuNt ntFJ}utop elf;fpy;; ;; ;; ; 
 espuhd fhw;WNk gdpNkw; gl;lhy;; ; ; ;; ; ; ;; ; ; ; 
 kpfuNt fha;fs; fdpfpoq;F jd;id; ; ; ;; ; ; ;; ; ; ;  
 kpftUe;jp kPwpNa japh;jhd; nfhz;lhy;; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; 
 KfuNt KJnfYk;ig KWf;fp nehe;J; ; ;; ; ;; ; ;  
 Koq;fhYk; fidf;fhYk; fLg;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  cz;lhNkh;;; ” 
. A+fp itj;jpa rpe;jhkzp ghly; ; ; ;; ; ;; ; ; - 28 
Walking for long distance and harmful combinations like fruits, vegetables 
and tubers causes toxic factors which affects bones and joints. 
 
According of Agathiar kanma kandam – 300 
“E}nyd;w thjk; te;jtif jhNd ; ; ;; ; ;; ; ;  
Jz;ikaha;f; fd;kj;jpd; tifiaf; NfS; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
fhypNy Njhd;wpaJ fLg;g NjJ; ;; ;; ;  
 iffhypy; Klf;fpaJ tPf;fNkJ; ; P ;; ; P ;; ; P ;  
 NfhypNy gLfpd;w tpUl;r khd; ;; ;; ;  
 Foe;ij kue;jd;id ntl;ly;Nky; Njhy; rPty;; ; ; ; ; ; ; P ;; ; ; ; ; ; ; P ;; ; ; ; ; ; ; P ; 
 ehypNy rPtnre;J fhy; Kwpj;jy;P ; ; ; ;P ; ; ; ;P ; ; ; ; 
 ey;y nfhz;G jio Kwpj;jy;eypj;jy; jhNd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
. mf];jpah; fd;k fhz;lk; ; ; ; ; ;; ; ; ; ;; ; ; ; ; - 300 ghly; 56;;;  
Agathiar kanma kandam -300 attributes the following psychological factors 
such as, breaking the animal legs, removing the bark of living trees. Cutting the trees 
in the living branches and removing leaves to be the cause for vatha diseases. 
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UTHIRA VATHA SURONITHAM 
Definition 
Uthira Vatha Suronitham is a condition which deals with the involvement of 
joints which comprises the symptoms of pain and swelling mainly in the small joints 
and also in large joints with lassitude and anorexia 
cjpuk;> RNuhzpjk; - FUjp 
thjk; - thA + Mfhak; 
 ,jid tsp> Rw;W> fhw;W> Cij> fhy; vd;Wk; $Wth;. 
tsp (thjk;) jd; mstpy; kpFe;jpUf;Fk; NghJ clypy; thjNeha;fs; 
Njhd;Wfpd;wd.  “A+fp itj;jpa rpe;jhkzp” E}ypd; gb 
 “vd;dNt thjkJ vz;gjhFk;” vd;W ghbdhYk; mitfspd; 
ngah;fisAk;> Fzq;fisAk; $Wk;NghJ vz;gj;ije;J tiffisf; 
$wpAs;shH mtw;wpy; xd;W “cjputhj RNuhzpjk;”. 
 
Clinical features of uthira vatha suronitham 
In Yugi Vaidhiya cinthamany 
      “itfpjkha;f; fZf;fhY Koq;fhy; jhDk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  kw;flQ; re;JGw tbAk; tPq;fpr;; ; ; ; P ; ;; ; ; ; P ; ;; ; ; ; P ; ; 
  nra;fpjkhQ; rpWtpu; ;; ;; ; y;fs; kpfTk; nehe;J; ; ; ;; ; ; ;; ; ; ;  
  rpe;ijjU khwpNa rypg;Gz; lhFk;; ; ; ;; ; ; ;; ; ; ;” 
  igfpjkhk; igj;jpaj;jpy; thj kpQ;rpg;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  ghukha; cw;gtpj;J moYz;lhFk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  ca;fpjkha; mrdkJ jhDk; Ntz;lh; ; ; ;; ; ; ;; ; ; ;  
  cjputhj RNuhzpjj; JzHr;rp ahNK; ;; ;; ;  
nghUs;;;; 
 fZf;fhy;> Koq;fhy;> re;Jfs; ,itfspy; tPq;Fk. Swelling in ankle 
joint, knee joint, dorsum of foot and other joints 
 moy; cz;lhFk< (Increased pitham) 
  (Loss of appetite) 
 rpWtpuy;fs; kpfTk; (Pain) gpwg;gpf;Fk;. (Pain in fingers that is interphalangeal 
joints) 
 rpe;ij jLkhWk; (Mental confusion) 
 rypg;Gz;lhFk; (Easy fatiguability 
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In Pararasasegaram, 
 “nghHrPNj Tjpu thj RNuhzpj Koq;fhy; jhDk; 
 nghw;fizf; fhYk; re;Jk; Gwtb jhDk; tPq;fp 
 ew;fZ tpuy;f ndhe;J eLg; gapj;jpa thjj;jpy; 
 cw;gtf; FzKKz;lh KWE}ypw; nrhd;d jhNk” 
cjputhj RNuhzpjj;jpy;; ;; ;; ; 
1. Koq;fhy;> fZf;fhy;> re;Jfs;> Gwtb (Dorsum of foot) Mfpa 
,lq;fspy; tPq;Fk; 
2. fZf;fhspy; cs;s tpuy;fs; NjhWk; typAz;lhFk; (Pain in 
metacarpophlangeal and interphalangeal joints) 
3. gapj;jpa thjj;jpy; fhZk; Fzq;fs; cz;lhFk; (Osteoporosis) 
Factors Stimulating Vatha Disease 
“njhopy; ngWifg;Gf;; ; ;; ; ;; ; ; fhHj;jy; jth;j;jy; tpRfpD NrhWk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
gioa jhk;tuF kw;iwg; ige;jpidaUe;jpdhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 vopy; ngwg; gfYwq;fp ,utpdpYwq; fhjyhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ;  
gpio epfh; FuypdhNy thjq; Nfhgpf;Fq; fhNz; ; ; ;; ; ; ;; ; ; ; ”  
 Intake of items excessive in bitter and astringent taste. 
 Intake of old cooked food items 
 Sleeping in the day time and awakening at night. 
“fhzNt kpfTz;lhYk; fUJgl;bdp tpl;lhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
khid ahHfz; Nkhfkwf;fpD kpFe;jpl;lhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
Mzt kyflk; ikaNd tplhjyhYk;; ;; ;; ; 
thDjd; kley;yhNs thjq; Nfhgpf;Fk; fhNd; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
 Excessive intake of food 
 Starvation 
 Excessive sexual desire 
“ghhpdpw; gag;gl;lhYk; gyUld; Nfhgpj;jhYk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
fhnudf; fUjpNahbf; fOkuj;Juj;jpdhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
VHngW jdJ nurpd; kpfj;Jf;f kile;jpl;lhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
ghhpa fhw;wpdhYk; glhpDk; thjq; fhZk;; ; ; ; ;; ; ; ; ;; ; ; ; ;”. 
 Fear 
 Anger 
 Excessive running 
 Stress 
 Exposure to wind daily 
9 
 
“fhyq;fz; khwpAz;Zk; fhhpaf; ; ; ; ; ;; ; ; ; ;; ; ; ; ; jhYe;jz;zPH; ; P; ; P; ; P  
rhyNt aUe;jpdhYk; re;jpapYl; fhHe;jhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
Nfhykhk; Gspg;G nea;ik Fiwtw tUe;jpdhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
thythH Kiyey;yhNd thjKw; gypf;Fq; fhNz; ; ; ;; ; ; ;; ; ; ; ” 
. A+fp itj;jpa rpe;jhkzp; ;; ;; ;  
Fsph; fhw;wpy; cl;fhHe;jpUj;jy;> Gspg;G> nea; cztpy; kpFjpahf 
Nrh;j;J nfhs;sy;> fhyk; jtwp cz;zy; Mfpa fhuzq;fspdhy; thjk; 
Njhd;Wk;. 
  “fhzNt kpfTz;lhYq; fUJgl;bdp tpl;lYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
khdid ahHfz; Nkhfkpwf;fpD kpFe;jpl;lhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
Mzt kyq;flik aq;qNd tplhjjhYk;; ; ;; ; ;; ; ; 
  thDjd; kley;yhNs thjq;Nfh gpf;Fq;fhNz; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
 mjpf msT cz;zy;> gl;bdp fplj;jy;> Mztk; mjpfhpj;jy; 
Mfpatw;why; thjNeha;fs; Njhd;Wk;. 
“tsp jU fha;fpoq;F tiutpyh japyy; Nfhio ; ; ;; ; ;; ; ;  
 Ksp japh; Nghd;kpFf;F Kiwapyh Tz;b Nfhly;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 Fsph;jU tspapw; Nwfq; Fdpg;Gw Tyty; ngz;bH; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 Fspj;jU Kaf;fk; ngw;NwhH fb nray; fUtpahkhy;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;” 
- rghgjp ifNaL 
 
EXTRINSIC FACTOR 
 Exposure to dampness and cold 
 Sleeping during day time 
 Month from aani to karthigai 
INTRINSIC FACTOR 
 Intake of old cooked food 
 Drinking rain water 
 Intake of food items which excess in bitter,astringent,and pungent taste 
SIDDHA PATHOLOGY 
 Siddha system of medicine is based on Thirithodam theory.  They are vatham, 
pitham and kapham the manifestation of all diseases are result of derangement of 
these uyir thathus (Thirithodam) 
           When the seven thathu and mukkutram are in equilibrium, a normal structural 
and physiological state of body is ensured.As the thathu are affected by the extrinsic 
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and intrinsic causative factors there will be distortion in the structural and functional 
state of the body. 
In Uthiravatha suronitham 
1. Vatham – increased 
“thjkyhJ NkdpnflhJ” 
Different kinds of vatham 
1. Uyir kaal – Praanan (Respiratory functions) 
“........ eykhd Fznky;yhk; gpuhz thA; ;; ;; ;  
gd;dNt ePytz;zk; nja;tk; re;jpud;; P ; ; ; ; ; ;; P ; ; ; ; ; ;; P ; ; ; ; ; ; 
gyg;gythk; nghrpg;ngy;yhk; rPuzkhFk;.; ; ; ; ; P ;; ; ; ; ; P ;; ; ; ; ; P ;  
. A+fp Kdpth;;;; 
This is the force of vital airs.  According to Yugi muni, pranan starts from 
Moolatharam and comes through the nostril and dose inspiration and expiration.  The 
inspiration and expiration is not uniform as the ratio is 8:12 there by the process of 
respiration is not complete.  The praana helps in the digestion of ingested food. 
2. Keel Nokku Kaal – Abanan (Excretory funtion) 
“....... kUf;fNt fPo;Nehf;fp kyrye;js;Sk;; P ; ; ; ; ;; P ; ; ; ; ;; P ; ; ; ; ; 
thfhf epwe;jhDk; gr;ir ahfk;; ; ; ;; ; ; ;; ; ; ; 
mUf;fNt ahrdj;ijr; RUf;fp itf;F.....; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
Abanan, the downward air, starts from swathittanam and descends down and 
is responsible for excretion of urine and faeces.  It contracts the anus.  It helps to take 
the essence of the digested food to the different parts of the body. 
3. Vyaanan (Perfusion of oxygen nutrients) 
“jWg;ghd rutrue; jdpNy epd;W; ; ;; ; ;; ; ;  
jhdPl;lhy; Klf;fy; gz;zpg; ghprkwpAk;P ; ; ; ; ; ; ;P ; ; ; ; ; ; ;P ; ; ; ; ; ; ; 
mWg;ghd td;drh ; ;; ;; ; ue;jd; idj;jhd; .....; ; ; ;; ; ; ;; ; ; ; ” 
Vyaanan arises from the shoulders and go through all the 72,000 nerves and 
thus activate voluntary and involuntary movements of the body and thus make them 
to extend or contract.  This appreciates the sense of touch, helps to take the essence of 
the food to the strategic points of the body and guards the body. 
4. Udhaanan (Reverse peristalsis) 
 It is responsible for the physiological reflex actions like vomiting , hiccup, 
cough etc., 
 
11 
 
 
5. Samaanan (Homestatic functions) 
 “.....thnkd;w;;;  thAtpd; kpQ;nrhl;lhky;; ; ; ;; ; ; ;; ; ; ; 
 klf;fpNa rkd;nra;J kUtg; gz;Zk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 jhnkd;w mWRitiaj; jz;zPH ud;dk;; ; ; P ; ;; ; ; P ; ;; ; ; P ; ; 
 rkd; nra;J rhPunkyhQ; rhug;gZk;.....; ; P ; ; ;; ; P ; ; ;; ; P ; ; ; ” 
Samaanan starts from the umblical cord and spread out upto the lower limb.  
This is responsible for the balance of the other four vathas.  It equalises the six tastes, 
water, food etc. and helps in assimilation. 
6. Naakan (higher intellectual functions) 
 It is responsible for the intelligence of an individual waking, singing and pilo 
erection. 
7. Koorman (Constrictory functions) 
 It is responsible for yawning, closing of mouth winking, shedding of tears, 
vision and opening of the eyes. 
8. Kirukaran (secretory functions) 
 “....... frpTz;lhq; fLk;grpapw; fd;kQ; nry;Yk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 fz;zpNa apUj;jnyhL Nghj yhFk;; ; ;; ; ;; ; ; 
 JrpTz;lha;j; Jk;kNyh bUk ; ; ; ;; ; ; ;; ; ; ; Yz;lhk;...; ;; ;; ; ” 
 Kirukaran lies in the tongue and causes nasal and salivary secretions.  It 
induces hunger, it makes to concentrate one thing, sneezing and cough are attributed 
to kirukaran. 
9. Devathatan (Mental and physical sluggishness) 
 It is responsible for laziness, quarrelling, arguing. 
10. Dhananjayan (Bloater of the body) 
 It leaves the body by blowing up the cranium only on the third day after death. 
In case of Uthiravatha suronitham 
S.No. Vatham Affected 
1. Abanan Constipation 
2. Vyaanan Restricted joint movements 
3. Samaanan Due to derangement of other vayus 
4. Kirukaran Loss of appetite 
5. Dhevathatan Insomnia 
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II. PITHAM 
Types of Pitham 
1. Anar pitham 
 Its action is characteristic of theyu.  This is responsible for dryness and 
digestion of food. 
2. Ranjaga pitham 
 It is responsible for the colour and contents of the blood. 
3. Saathagam 
 It controls the whole body.  It is responsible for the action what we think. 
4. Aalosagam 
 It is responsible for the vision. 
5. Prasagam 
 It is responsible for the vision. 
In case of Uthiravatha suronitham 
S.No. Pitham Affected 
1. Anal pitham Loss of appetite 
2. Ranjaga pitham Pallor due to low Hb 
3. Saathaga pitham Difficulty in walking, climbing upstairs, squatting etc. 
4. Prasaka pitham Skin pallor 
 
III. KABHAM 
 Kapha has been further divided into five as follows. 
1. Avalambagam 
 Lies in lungs, controls the heart and other kabhas. 
2. Kilethegam 
 Lies in stomach, makes food soft and helps in digestion. 
3.Pothagam 
 Responsible for identifying tastes. 
4. Tharpagam 
 Present in the head and responsible for the coolness of both eyes. 
5. Santhigam 
 It lies in the joints and responsible for the action of joints.  The above function 
may be altered whatever the mukkutram is altered. 
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In case of uthiravatha suronitham 
S.No. Kabam Affected 
1. Klethagam Loss of appetite 
2. Santhigam Restricted movements of joints. 
 
PINIYARI MURAIGAL (METHOD OF DIAGNOSIS): 
It is based upon three main principles. 
i) Poriyal Arithal (Inspection) 
ii) Pulanal Arithal (Palpation) 
iii) Vinaathal Arithal (Interrogation) 
i) Poriyal Arithal  
  Pori means “Five Sense Organs”  
1. Mei (Skin) 
2. Vai (Tongue) 
3. Kan (Eye) 
4. Mookku (Nose) 
5. Sevi (Ear) 
ii) Pulanal Arithal 
  Pulan are five senses. They are, 
1. Smell 
2. Taste 
3. Vision 
4. Sensation of touch (palpation) 
5. Hearing 
  “Pulanal Arithal” means examining the “Pulan” of the patient by the “Pulan” 
physician to diagnose a disease. 
iii) Vinaathal Arithal 
Vinaathal is collect the  information  the history of disease, its clinical features 
etc, from the patient or his / her close relatives useful when the patient is unable to 
speak or in the case of a child.  
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DIAGNOSTIC METHODOLOGY IN SIDDHA SYSTEM OF MEDICINE 
ENVAGAI THERVUGAL (EIGHT DIAGNOSTIC TOOLS) 
These Tools not only help in the diagnosis but also helps to observe the 
prognosis of the diseases and for reassuring the patient and to be informed about the 
nature of diseases, they are 
1. Naadi (Pulse)     
2. Sparisam (Sensation to Touch)   
3. Naa (Tongue)                 
4. Niram (Colour) 
5. Mozhi (Voice) 
6. Vizhi (Eyes) 
7. Malam (Faeces) 
8. Moothiram (Urine) 
 
Naadi (Pulse) 
 The study of ‘Naadi’ is the important diagnostic stool in Envagai thervugal 
which gives almost the correct diagnosis.  This  method developed by siddhars to 
extend our sensual perceptions to the interior of our body to diagnose and confirm 
illnesses. The study of naadi at hand is the best because the radial artery is located 
superficially, the unique factor which pertaining the soul in the body is known as 
“Naadi”.  Naadi is felt in right hand for males and left hand for females.  It is usually 
felt using 3 fingers (viz index, middle and ring fingers) in view of assessing the states 
of vatham, pitham, kabham in the ratio of 1: ½ : ¼ normally.  Derangement of this 
ratio leads to various disease. 
 “fhp Kfdbia tho;j;jp ; ;; ;; ;  
ifjdpy; ehb ghHf;fpy;; ; ;; ; ;; ; ; 
ngUtpuyq; Fyj;jpy;; ; ;; ; ;; ; ; 
gpbj;jb eLNt njhl;lhy;; ; ;; ; ;; ; ; 
xU tpuNyhby; thjk;; ;; ;; ; 
cah; eL tpuypy; gpj;jk;; ; ; ;; ; ; ;; ; ; ;  
jpU tpuy; ;;; %d;wpNyhby;; ;; ;; ; 
jpU tpuy; %d;wpNyhby;; ; ;; ; ;; ; ; 
 rpNyj;Jk ehb jhNd;;; ” 
. mfj;jpah; ; ;; ;; ; -2000 
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In Uthira vatha Suronitham, vatha kalappu Naadi will be felt. 
Vadha Naadi 
 “thjnkDk; ehbaJ Njhd;wpy;; ; ;; ; ;; ; ; 
 rPjke;jnkhL tapW nghUky; jpul;rptha;TP ; ; ; ;P ; ; ; ;P ; ; ; ;  
 rPjKWq; fpuhzp kNfhjuk; ePuhikP ; ; PP ; ; PP ; ; P  
 jpus;tha;T ; ;; ;; ; #iy typfLg;Gj; jPu; ; P; ; P; ; P  
 ePuKWq; fpUkpFd;kk; mz;lthjk;P ; ; ; ; ;P ; ; ; ; ;P ; ; ; ; ; 
 epiyAk; ePHf;fphpr;ruq;fs; je;J Nkfk;; P ; ; ; ; ; ;; P ; ; ; ; ; ;; P ; ; ; ; ; ; 
 Ngjfkh Kjug;gpzp %y Nuhfk;; ;; ;; ; 
 NgrntF gpzpfSNk nghUs jhNk” 
. rjf ehb 
Vatha Pitha Naadi 
 “nghUshd thjj;jpy; gpj;jQ; Nrh;e;J; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 nghUe;J Fzq;fsh K; ;; ;; ; \;zthA rf;jp; ;; ;; ;  
 nrhpahik Gspj;Nj;;; g;gk; nghUky; ephpw;; ; ; ;; ; ; ;; ; ; ; 
 rptg;Gkyk; gpbj;jYUe; jhJ el;lk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 fUthd Njfkjp Yisr;ry; Nrhk;gy;; ; ; ;; ; ; ;; ; ; ; 
 iffhy; jwpg;Gehf; frf;F kd;dk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 ghpthd Cz;Fiwjy; UrpNf lhjy;; ; ;; ; ;; ; ; 
 gyNehAk; tUj;jpitf;Fk; ghq;F jhNd; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
. rjfehb 
2. Sparism (Palpation) 
 Skin examination reveals about the warmthness/chillness , dry/weeping skin, 
rough/smooth, soft/hard, tenderness, presence of ulcers, fissures, swelling, wrinkle, 
hair pigmentation etc. 
 In Udhira vatha suronitham the affected part may feel warm with swelling and 
tenderness. 
3. Naa (Tongue) 
 The colour changes according to changes in Mukkuttram, coated tongue, 
dryness, Jaundice, cyanosis, paleness, ulcer, peeling of skin, fissures, teeth marks in 
the border, tumours, taste, deviation of the tongue and excessive salivation should be 
noted.  
 In Udhira vatha suronitham the tongue may be dry and coated.  If anamia is 
present, the tongue may be pale. 
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4. Niram (colour) 
 By the examination of niram, the type of dhegam (body) cyanosis, redness, 
pallor, yellow discolouration can be noted. 
 Vatha Dhegi  - Dark colour 
 Pitha Dhegi - Yellow or red colour 
 Kabha Dhegi - White or yellow colour 
5. Mozhi (Speach or voice) 
 In the examination of mozhi, the pitch of voice (low or high) action of 
laughing, crying, slurring and speech in hallucination can be noted. 
6. Vizhi (Eye) 
 Changes according to mukkutram, redness of eyes, ulcers, other diseased 
conditions should be noted. 
7. Malam (Stools) 
Vatha type : Black colour, stools with constipation. 
Pitha type : Loose stools with yellowish red colour 
Kapha type : White coloured stools with muccus 
Thontha type : Stools possess some of the features of two doshas. 
 Other examinations like diarrhoea, presence of blood, ova, cyst odour should 
be noted. 
In uthira vatha suronitham constipation may be present. 
8. Moothiram (Urine) 
 The examination of urine is classified into two types 
1. Neer kuri 
2. Nei kuri 
1. Neerkuri 
 Niram indicates the colour of the urine 
 Edai indicates the specific gravity of urine 
 Manam indicates the smell of the urine 
 Nurai indicates the frothy nature of the urine 
 Enjal indicates the quantity (increasd or decreased) and deposits of urine 
voided. 
In addition, frequency of micturition and sediments are noted. 
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2. Neikuri 
 “mUe;J khwpujKk; mtpNuhj kjha;; ; ;; ; ;; ; ; 
 m/fy; myh;jy; mfhy T+z; jtph;e;jow;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 Fw;ws tUe;jp ; ;; ;; ; cwq;fp itfiw;;;  
 Mbf; fyrj; jhtpNa fhJnga;; ; ;; ; ;; ; ; 
 njhU K$Hj;j fiyf;Fl; gLePhpd;; ; ; P ;; ; ; P ;; ; ; P ; 
 epwf;Fwp nea;f;Fwp epUgpj;jy; flNd; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
. Njiuah<< << 
Procedure  
 Prior to the day of urine examination for neikuri, the patient is advised to take 
a balanced diet and the quantity of food must be proportionate to his appetite.  The 
patient should have a good sleep.  After waking up in the morning the first voided 
urine is collected in a glass container and is subjected to analysis withing one and half 
hours. 
 A drop of gingelly oil is dropped over urine without disturbing the nature of 
the neikuri should be noticed in direct sunlight.  The spreading pattern exhibited by 
the oil droplet over the surface of urine gives a confirmatory clue that helps in the 
disease. 
 
SEVEN UDAL THATHUKKAL 
1. Saaram Strengths the body and mind. 
2. Senneer Gives power, knowledge and boldness to the 
mankind. 
3. Oon It strengthens the body. 
4. Kozhuppu It lubricates the joints. 
5. Enbu It protects all the internal organs and gives the 
structure to the body. 
6. Moolai It is present in the bone marrow 
7. Sukkilam and 
Suronitam 
Reproduction 
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S.No. Udal 
kattukal 
Decreased features Increased features 
1. Saaram Loss of weight,  lassitude,  
Dryness of the skin,  
Diminished activity of sense 
organs 
Leads to disease identical to 
increased kabham, like loss 
of appetite, profuse 
salivation, depression etc. 
2. Senneer Tiredness, Lassitude, Anaemia, 
Dryness 
Increased blood pressure 
Reddish eye and skin 
jaundice, Haematuria, Boils 
and tumors in different parts 
of the body. 
3. Oon Muscle wasting,  lethargic 
sense organs 
Extra growth around neck, 
face, abdomen, thigh, 
genitalia etc. 
4. Kozhuppu Joint pain,  Emaciation, 
Splenomegaly. 
It leads to identical features 
of increase oon associated 
with dyspnoea on exertion 
5. Enbu Joint pain, falling of teeth, 
splitting and falling of hair and 
nails. 
Excessive ossification and 
dentition. 
6. Moolai Osteoporosis of the bone,  
blurred vision. 
Obesity,  swelling of 
interphalangeal joints, 
oliguria, Non-healing ulcers. 
7. Sukkilam 
(or) 
Suronitham 
Pain in the genitalia failure to 
reproduce 
Increased sexual activity , 
Increased formation of 
urinary calculi. 
 In uthiravatha suronitham saaram, seneer, oon, kozhuppu, enbu are commonly 
affected. 
 TYPES OF VATHA SURONITHAM IN YUGI CYINTHAMANI 
• Vadha Suronitham 
• Sithuvatha Suronitham 
• Vaithiya Vatha Suronitham 
• Paithiya Vatha Suronitham 
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• Slethumavatha Suronitham 
• Utharavatha Suronitham 
• Uthiravatha Suronitham 
rpj;JthjRNuhzpjk;; ;; ;; ; 
“thwhd rhPunky;yh Eioe;J Cjy; 
  khrw;w Njhy;jhDe; jpiue;J NghFk; 
 ehwhd ehWNghy;e uk;G Rf;Fk; 
  ehf;Fj;jhd; totoj;Jf; Nfhio ahFk; 
 Ehwhd neUg;Gj;jhd; gl;lhw; Nghy 
  nehe;JNk rlnky;yhk; nfhg;g spf;Fk; 
 tPwhd Thpe;Jgpd;id ntJk;gp tPq;Fk; 
  kpf;frpj; JthjRNuh zpjk jhNk”. 
SITHUVATHA SURONITHAM 
 Anasarca. 
 Wrinkles. 
 Neural pain. 
 Glossy tongue. 
 Sialorrhoea. 
 Bullous eruption as in burn. 
 Exfoliation, swelling  and Warmthness. 
Nrj;JkthjRNuhzpk;; ;; ;; ; 
“gz;ghf Tly;FspHe;J VW tPq;fpg; 
 gijg;ghd tple;njhl;lhw; ghu Nehthk; 
jpz;ghd rpuRnew;wp Nehf;fh Lz;lhk; 
 rpNyl;L kkha;f;Nfhio nahLR thrkhFk; 
kz;ghf kaf;f nkhL fdT Kz;lhk; 
 tha;tuz;L Urpapy;yh tUj;j khFk; 
ez;ghf ehbANk gl glf;Fk; 
 ew;Nrl;g RNuhzpjkhk; ehLq; fhNy”. 
SLETHUMAVATHA SURONITHAM 
 Chillness with abdominal distension. 
 Severe pain and Head ache. 
 Syncope and Hallucination. 
 Dryness of mouth and Anorexia. 
 Tachycardia. 
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cjuthjRNuhzpjk;;;; 
 “ehLNk Ruk;te;J eLf;f Yz;lhk; 
  ehtuz;L jiynehe;J clk;g Oj;jp 
 thLNk Njfnky;yh kdpr;rg; G+g;Nghy; 
  kfhtUj;j Kz;lhfp kaf;f khFk; 
 rhLNk abf;fbjhd; Ngjp jhDk; 
  jtpf;FNk jz;zPHjh dhl;l khfpj; 
 NjLNk Nrhw;wpd;Nky; epidT jhDk; 
  nraTju thjRNuhzp je;jh ndd;Nd”. 
 
UTHARAVATHA SURONITHAM 
  Fever with rigor. 
 Dryness of mouth. 
 Pain in all over the joints. 
 Headache. 
 Diarrhoea. 
 Excessive thirst. 
 Hunger. 
 
itfpjthjk;;;; 
 “Mnkd;w tPq;fpdNjhH tplj;jpy; uj;jk; 
  mOj;jkha;j; jpuz;LNk vq;Fk; gha;e;J 
 Xnkd;W Xl;bNajp uz;b Uf;Fk; 
  cWjpaha;j; njhl;LlNd nkj;njd; whFk; 
 Njnkd;w Njfnkq;f ZK Rf;Fk; 
  rPwpa NjhhpUknyhL fhr;r Yz;lhk; 
 ghnkd;w gle;jdpNy jpkpUz; lhFk; 
  ghukha; itfpjkhk; thje; jhNd”. 
-  A+fp itj;jpa rpe;jhkzp 
Uthiravatha Suronitham is differentiated from other types of Vatha 
Suronitham as follows: 
 
VAIKITHA VATHA SURONITHAM 
 Swelling with hyperaemia. 
 Soft on touch. 
 Cough with pyrexia. 
 Irritability. 
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itfpjthjk;;;; 
 “Mnkd;w tPq;fpdNjhH tplj;jpy; uj;jk; 
  mOj;jkha;j; jpuz;LNk vq;Fk; gha;e;J 
 Xnkd;W Xl;bNajp uz;b Uf;Fk; 
  cWjpaha;j; njhl;LlNd nkj;njd; whFk; 
 Njnkd;w Njfnkq;f ZK Rf;Fk; 
  rPwpa NjhhpUknyhL fhr;r Yz;lhk; 
 ghnkd;w gle;jdpNy jpkpUz; lhFk; 
  ghukha; itfpjkhk; thje; jhNd”. 
-  A+fp itj;jpa rpe;jhkzp 
Uthiravatha Suronitham is differentiated from other types of Vatha 
Suronitham as follows: 
VAIKITHA VATHA SURONITHAM 
 Swelling with hyperaemia. 
 Soft on touch. 
 Cough with pyrexia. 
 Irritability. 
SIRAPPU MARUTHUVAM FOR VATHA DISEASE 
1. xw;wlk; 
2. NtJ 
3. njhf;fzk; 
4. Mrdk; 
5. gpuhzhahkk; 
6. jpahdk; 
SPECIFIC TREATMENT FOR UTHIRA VATHA SURONITHAM 
(STEAM BATH)  
 clypUe;J tpaHit ngUFk;gb nra;tjw;F Vw;wKiwfspy; 
xd;W NtJ. 
 ePiur; rpy %ypiffSld; NrHj;J nfhjpf;f itj;J mjdpd;W 
vOk; Mtpia gpbj;jy;. 
A steam room is an enclosed space with large amounts of high temperature 
steam, creating a high humidity environment. People sit in this room in a similar way 
to a sauna (conversely a hot, but dry atmosphere), for relaxation and purported 
benefits to health and well being. Steam rooms are commonly maintained at a 
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temperature of 41 degrees Celsius or above, with a high humidity of around 100% 
adding to the sensation. 
The benefits of a steam bath are numerous. Some of the benefits include: 
 The most common and obvious reason is to relieve tension buildup and 
various forms of stress. 
 Various ailments such as arthritis, muscle pains and the like can be 
relieved because of its warm effect to the body. 
 Old people will surely benefit from this since joint pains and other body 
pains can be relieve. 
 Steam rooms due to its heat effect make you sweat a lot thus your body 
will eventually release toxins and other negative energies. 
 It will also regulate and stimulate the flow of your blood and make your 
metabolism works faster. 
 It also makes your skin looks fresh, young looking and truly healthy. 
 It can give you a lot of self-confidence due to the good effects it will cause 
to your personal appearance. 
 Increases circulation for healthier skin & more energy. 
 Relaxes stiff muscles & ceases swelling or tension in joints associated with 
arthirits. 
 As well as nutrients also gets pushed to the surface of the skin, which may 
have a positive effect on collagen production. Collagen makes bones 
stronger and helps cell regeneration. That part about cell regeneration 
makes it partially accountable for firmer skin. 
Anyone suffering from sleeping disorders, poor skin circulation & Muscular 
tension & Weakness will benefit from taking a steam bath. 
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STEAM BATH  
Introduction 
   A room that is filled with hot steam for the purpose of cleansing and Steam 
bath refreshing the body and for relaxation. It is a restorative concept of steam, to 
revive our overall health and enhance appearance. 
Types 
   The difference between a sauna and a steam room can be summed up simply -- 
dry vs. wet. Sauna provides dry heat, while steam room generates moist heat. Both 
can open up your pores, loosen up your muscles and help you relax 
Prepatory procedure 
   Take a shower before you use the steam bath to remove dirt and oils. Remove 
any metal jewellery. Metal conducts heat very efficiently and can heat up in the steam 
room to the point where it could be uncomfortable or even burn you. And 
recommends you remove the contact lenses before enter the steam room. 
 Dress code 
   For mens is shorts and for womens is towel and preferred material is cotton 
Rest 
  Patient can lie down, plan to relax. Ask to close the patient eyes if you like, 
breathe deeply and focus on letting the heat soak in and relax you. Remain there as 
long as you are comfortable, which can be as little as 5 minutes or as long as 20 
minutes. 
Recover 
  Take a cool shower, then rest and allow your body to return to normal 
temperature. Drink some water and enjoy this break from a busy day. 
 
Merits and demerits 
Vasodilatation -Benefits 
  Both steam rooms and dry saunas cause the blood vessels in the skin to dilate, 
in part accounting for the warm glow appearance afterwards. The blood flow out of 
the heart increases by 2 or more times after a 10 to 15 minute steam room or sauna 
exposure. 
Risks :  
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  However, the blood flow to the internal organs actually decreases, because so 
much blood is being directed to the skin instead. This can be a problem for folks with 
coronary heart disease. 
Analgesia –Benefits: 
  Heat has long been recognized as beneficial for folks with fibromyalgia, 
arthritis and other painful conditions. 
Risks: 
  If heat exposure is extreme, excessively prolonged, or if the individual has 
underlying irritation of the skin, heat can cause the equivalent of a sunburn, or thermal 
burn. 
In addition, steam exposure may be a concern if you have had recent 
surgery(particularly if sutures are still in place) or if you have an open or infected 
wound. 
Antispasmodic 
Benefits: 
  Heat tends to cause relaxation of the musclesand many individuals note 
improved recovery ofmuscle soreness and decreased problems with delayed muscle 
soreness when they use a sauna or steam room after exercise. 
Diaphoresis (sweating)–Benefits: 
  The average person will sweat about a pint during a 15 minute session in a 
sauna, depending on the person’s acclimatization to heat exposure. This has 
theoretical benefits for cleansing skin pores and some people believe sweating helps 
clear toxins from the body. This is not well proven and in many in stances, is simply 
not true. In general, people with documented toxicant accumulation in their bodies 
benefit from specific medical treatment directed at the specific toxicants, rather than 
sweating. In addition, many of the toxicants of concern these days, for example: 
pesticides and many metals, asbestos, are not cleared very well through the sweat. 
Risks: 
  The effect of both wet and dry heat to increase fluid loss from the body can 
also be a problem, particularly in folks who are already somewhat dehydrated (e.g. 
after heavy exercise within adequate fluid replacement or in response to the diuretic 
effects of caffeine, beverage alcohol, and medications (diuretics). Dehydration can be 
a problem in people who have blood vessel blockages to the  brain and the heart. 
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Some individuals experience an increase in their migraine headaches in response to 
dehydration. 
  There are a number of other medications that can affect the body’s normal 
response to heat either by inhibiting sweating or by otherwise interfering with the 
normal physiology, for example, some medications used for psychiatric conditions 
like schizophrenia. Use of stimulant medications for conditions like ADD or 
excessive sleeping also increases the health risks from heat exposure. 
Sedative-Benefits:  
  Heat exposure through a dry sauna or steam room causes a sense of relaxation 
for many people, with both muscle relaxation and a reduction in the sense of stress 
and  anxiety. Many people find use of steam rooms and saunas  improves the quality 
of their sleep 
Expectorant–Benefits:  
  Steamheat (not dryheat) can have therapeutic benefits for thinning mucous 
lining it easier for some individuals to cough up phlegm.Itcan also free up sinus 
passage ways and Eustachian tubes in individuals with sinus and Eustachian tube 
problems. 
Risks: 
  This same effect can trigger increased problems with wheezing and chest 
tightness in some asthmatics and other individuals lung disease, particularly if they 
have noted problems when taking a steamy shower previously. 
Calorie Burn Benefits:  
   Although exposure to heat increases energy consumption and there by 
increases calorie burn, for example, up to 300 to 400 Kcal during 20 to 30 minute 
sauna bath, us helping to promote weight loss,  
Risks: 
  Individuals who have been cautioned to restrict exercise intensity by health 
care providers should be aware that the effects of heat are similar to those of exercise 
for increasing heart rate. 
  Increasing energy consumption through  increased work of the heart can be a 
concern for people with coronary heart disease, congestive heart failure, valvular 
heart disease or heart rhythm problems  
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Scientific evaluation 
  Although sauna bathing causes various acute, transient cardiovascular and 
hormonal changes, it is well tolerated by most healthy adults and children.. Some 
studies have suggested that long-term sauna bathing may help lower blood pressure in 
patients with hypertension and improve the left ventricular ejection fraction in 
patients with chronic congestive heart failure, but additional data are needed to 
confirm these findings. Sauna bathing may also alleviate pain and improve joint 
mobility in patients with rheumatic disease. Although sauna bathing does not cause 
drying of the skin-and may even benefit patients with psoriasis-sweating may increase 
itching in patients with atopic dermatitis. Contraindications to sauna bathing include 
unstable angina pectoris, recent myocardial infarction, and severe aortic stenosis. 
Sauna bathing is safe, however, for most people with coronary heart disease with 
stable angina pectoris or old myocardial infarction. Very few acute myocardial 
infarctions and sudden deaths occur in saunas, but alcohol consumption during sauna 
bathing increases the risk of hypotension, arrhythmia, and sudden death, and should 
be avoided. 
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MODERN ASPECT 
RHEUMATOID ARTHRITIS 
 
  The term rheumatoid arthritis was first used by Sir Archibald  Garrod in 1876 
to describe a chronic non-suppurative inflammatory arthropathy distinct from gout 
and osteoarthritis. It is generally regarded as an auto-immune disease but details of  its  
pathogenesis  remain unclear. Its prevalence is remarkably consistent worldwide 
(approximately 1 per cent) with a few important exceptions that have helped to 
highlight environmental influences and the role of the immune response genes. 
Inflammation of the synovial joints leading  to  destruction of joints and peri articular 
tissues is, the most  obvious  clinical and pathological characteristic of the disease, but 
a wide variety  of extra-articular features can also develop. 
  Rheumatoid Arthritis is a chronic multisystem  disease affecting the 
connective tissues of the whole body with  focalised involvement of the 
musculoskeletal system. The characteristic feature of  established RA is persistent 
inflammatory synovitis usually involving  peripheral joints  in a systemic distribution. 
The potential of Synovial inflammation  to cause cartilage damage, bone erosions and 
subsequent changes in joint integrity is the hallmark of the disease. The course is 
variable despite of destructive potential. Some patients experience a mild oligo 
articular illness of brief duration with minimal joint damage but most will have 
progressive polyarthritis with marked functional impairment clinical manifestations. 
RA is a chronic polyarthritis. In approximately 2/3 of  patients  it begins insidiously 
with Fatigue, Anorexia, generalized weakness, vague musculoskeletal symptoms until 
the appearance of synovitis becomes apparent. 
  Specific symptoms usually appear gradually as several joints, especially those 
of hands, wrist, knee and feet become affected in a symmetric fashion. In some of 
individuals constitutional symptoms, including fever, Lymphadenopathy, 
Spleenomegaly are present. 
 
Epidemology 
  The incidence og RA is in the region of 3  cases  per  10,000  population per 
annum. Onset is uncommon under the age of 15 and from then on the incidence rises 
with age until the age of 80. The prevalence rate is 1%,  with women affected three to  
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five times as  often as  men.  First – degree relatives prevalence rate is 2 – 3 % and 
disease genetic concordance in monozygotic twins is approximately 15 – 20%. 
It is strongly associated with the inherited tissue type major histocompatibility 
complex (MHC) antigen HLA – DRA (Most specifically DR0401 and 0104) – hence 
family history is an  important risk factor. 
 
Aetiology 
  Rheumatoid arthritis has a complex multifactorial aetiology. There is 
considerable evidence for an important genetic component. Twin studies indicate a 
concordance rate  of around 20 per cent   in  monozygotic twins, although this figure 
is probably influenced by the severity of the disease in the proband. 
  Rheumatoid arthritis has many similarities to reactive arthritis, in which a 
wide range of different Gram-negative organisms are known to trigger the disease, 
infection at sites distant from the joints has not been identified, inspite of claims that 
infections of urinary tract (Proteus sp) may be more common in patients with 
rheumatoid arthritis  than  in healthy controls. Likewise, no particular organism has 
ever been found reproducibly in the joints of patients with rheumatoid arthritis, 
although there have been sporadic reports of the isolation of viruses (rubella, 
parvovirus), atypical mycobacteria, and mycoplasma. 
  Some populations appear to be at unusually high or low risk of developing 
rheumatoid arthritis, and the study of these has yielded some clues to its aetiology. 
Certain genetic markers are associated with rheumatoid arthritis. The risk to the first-
degree relatives of probands  with mild, non-erosive, seronegative disease (2-3 per 
cent) is  little  greater than in the risk in the general population. 
 
The possible aetiological factors. 
 Genetic predisposition - Rheumatoid arthritis runs in  families.  It is 
associated with class II major histocompatability complex allele HLA - 
DR4 and HLA - DRB1. Genetic factors alone do not account for the 
disease. 
 Abnormal immune response : Rheumatoid arthritis may be a manifestation 
of an immune - mediated response to infections are caused by 
Mycoplasma, Epstein - Barr virus, Cytomegalovirus, parvovirus in a 
genetically predisposed individual. 
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Immune Over Activity 
1. Presence of Serum of abnormal immunoglobulin Rheumatoid factor IgG and 
IgM. 
2. Infiltration of synovial tissue by immunologically component cells, 
Lymphocytes, Plasma cells which are responsible for local production of Ig 
including Rheumatoid factor. 
3. Presence of immune antigen - antibody complexes within leucocytes in 
synovial fluid and peripheral blood. 
4. The finding of lower complement levels in synovial fluid. 
Signs of Symptoms of Articular Disease: 
 Pain, Swelling and tenderness may  initially be poorly localised to the joints. 
Pain is aggravated by movements. 
 Generalized Morning Stiffness of > 1 hr duration is a variable feature and is 
frequent and usually greatest after periods of inactivity. 
 Weakness, easy fatigability, Anorexia and weight loss are Present.  40oC fever 
on occasion may  be present sometimes and temperature elevation of >38oC 
suggest the presence of intercurrent problem such as infection. 
 Clinically synovial inflammation causes swelling, tenderness 
 and limitation of movement. Pain  Originates from  joint capsule which is 
abundantly supplied with pain fibres and is markedly sensitive to stretching or 
distention. Joint swelling results from accumulation of synovial fluid, 
hypertrophy of synovium and thickening of joint capsule. 
 RA most often causes symmetric arthritis with characteristic 
 involvement of certain specific joints such  as proximal interphalangeal joints 
and Metacarpophalangeal joints. 
 Synovitis of the wrist joints is a nearly uniform feature of RA with limitation 
of movements, deformity and median nerve entrapment (Carpel tunnel 
syndrome). 
 Synovitis of elbow joint often leads to flexion contracture. 
 The knee joint is commonly involved with synovial hypertrophy, chronic 
effusion and frequently ligamentous laxity. Bakers cyst is the extension of 
inflammed synovium into the popliteal fossa. 
 Arthritis in the forefoot, ankles of subtalar joints can produce  severe pain and 
deformities. 
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 Axial involvement is usually limited to the upper cervical spine  with 
inflammation from synovial joints and bursae of the upper cevical spine leads 
to atlantoaxialsubluxation. Accompanied by pain in occiput. On rare occasions 
it may lead to compression of spinal cord. 
A varitey of Characteristic joint changes occur 
 Laxity of supporting soft tissue structures. 
 Damage or weakness of ligaments, tendons and joint capsule. 
 Cartilage damage, muscle imbalance. 
 
Characteristic changes in Hand 
1. Radial deviation at wrist with ulnar deviation of digits often with palmar 
subluxation of the proximal phalanges ‘z’ deformity. 
2. Swan neck deformity 
3. Hyperextension of the Proximal interphalangeal joint with compensatory 
flexion of distal interphalangeal joints. 
4. Boutonniere deformity 
5. Flexion contracture of the proximal interphalangeal joints of extension of 
distal interphalangeal joints. 
6. Hyperextension of the first interphalangeal joint and and flexion  of the 1st 
metacarpophalangeal joint with a consequent loss of thumb mobility of pinch. 
Foot  
1. Changes  in  feet  with  eversion  at  the  hind  foot  (subtalar joint) plantar, 
2. Subluxation of metatarsal heads, widening of fore foot, Hallux valgus, 
3. Lateral deviation and dorsal subluxation of toes. 
Pathology 
  Rheumatoid disease is considered to be  an  autoimmune response  to an 
unknown antigen and the antibody formed is the rheumatoid factor which is identified 
as immunoglobulin M (Mostly IgM) or IgG (Less commonly). The Rheumatoid factor 
is an IgM antibody directed against the FC portion of IgG antibodies. 
  Rheumatoid arthritis is an inflammation of the synovial membrane which 
becomes Oedematous and thickened with inflammatory exudates. Chronic persistant 
synovitis is the characteristic feature of rheumatoid arthritis. 
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The disease follows three stages. 
 Synovitis  
 Destruction 
 Deformity 
 
 
 
 Lymphoid follicles forms nodules with scattered cells. 
 In later stages synovium is more vascular and throws a fibrous exudate which 
gets organised into a granulation tissue and spreads over the articular cartilage 
as the pannus. 
 The articular cartilage gets lysed from the surface. 
 The inflammatory process spreads into the capsule and the periarticular tissue. 
 During the healing process the granulation tissue pannus destroys the articular 
cartilage uniting the joint surface and causing a Bony ankylosis. 
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  The key considerations in the pathogenesis of the  disease  are  1) the nature of 
the autoimmune reaction, 2) the mediators of tissue injury, 3) genetic susceptibility 
and 4) the arthritogenic antigen. 
  The autoimmune reaction in RA consists of activated CD4  +  T cells, and 
probably B lymphocytes, and how they are  initially activated are still unknown. The 
T cells apparently function mainly by stimulating other cells in the joint to produce 
cytokines that are central mediators of the synovial reaction. Although the 
contribution of autoreactive B cells has been an issue of controversy, there is 
increasing evidence  that immune complex deposition may also play some role in the 
joint destruction. Perhaps, the major advances in our understanding of the disease 
have been a better appreciation of the actual mediators of joint injury. Cytokines are 
believed to play a pivotal role, and the most important of these cytokines are TNF and 
K-1. Both are probably  produced by macrophages and synovial lining cells that are 
activated by the T cells in the joint TNF and IL-1 in turn, stimulate synovial cells to 
proliferate and produce various mediators of inflammation (such  as prostaglandins), 
and matrix metallo proteinases that contribute to cartilage destruction. Activated T 
cells and synovial fibroblasts also produce RANKI, which  activates osteoclasts and 
promotes bone destruction. Thus a chain of events is set up that leads to progressive 
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joint damage. The hyperplastic synovium rich in inflammatory cells become adherent 
to and grow over the articular surface, forming a pannus, and stimulates resorption of 
the adjacent cartilage. In the  end,  the pannus produces sustained, irreversible 
cartilage destruction and erosion of subchondral bone. The realization of the 
important roles of  TNF and IL-1 is the basis for the successful use of anticytokine 
therapy, especially against TNF. 
  Genetic susceptibility is a significant component of the development of RA. 
There is a high rate of concordance between monozygotic twins and a well defined 
familial predisposition. Multiple gene loci are beleived to be responsible for 
susceptibility to the disease, but most of these have not been identified yet. One 
susceptibility gene  that is known is in the class II HLA locus and specifically a region 
of 4 amino acids located in the antigen binding cleft that is shared in HLA DR BI 
0401 and 0404 alleles. This HLA-DR allele may bind and display the arthritogenic 
antigen to T cells, although there is no formal evidence  in support of this idea. 
The antigen that trigger autoimmunity and precipitate the reaction are not known. 
There has been great interest in exploring microbial antigens, as the initiating triggers, 
but no firm evidence has definitively identified a microbial organism as an etiologic 
agent in rheumatoid arthritis. 
EXTRA – ARTICULAR MANIFESTATIONS 
Systemic: 
 Fever 
 Weight loss 
 Fatigue 
 Susceptibility of infection 
Vasculities: 
 Digital arteritis 
 Ulcers 
 Pyoderma gangrenosum 
 Mononeuritis multiplex 
 Visceral 
Musculoskeletel: 
 Muscle wasting 
 Tenosynovitis 
 Bursitis 
 Osteoporosis 
Cardiac: 
 Pericarditis 
 Myocarditis 
 Endocarditis 
 Conduction defects 
 Coronary vasculitis 
 Granulomatous arthritis 
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Haematological: 
 Anaemia 
 Thrombocytosis 
 Eosinophilia 
Nodule: 
 Sinuses 
 Fistula 
Lymphatic: 
 Spleenomegaly 
 Felty’s syndrome 
Pulmonary: 
 Nodules 
 Pleural effusion  
 Fibrosing alveolitis 
 Bronchiolitis 
 Kaplan’s syndrome 
Occular: 
 Episcleritis 
 Scleritis 
 Scleromalacia 
 Kerato conjunctivitis sicca 
Neurological: 
 Cervical Cord compression 
 Compression neuropathies 
 Peripheral neuropathy 
 Mononeuritis multiplex 
 Amyloidosis 
 
Frequency Joint involvement in Rheumatoid arthritis 
1. MCP / MTP / PIP joints - 90% 
2. Knee, ankle, wrist joints - 80% 
3. Shoulder joint - 60% 
4. Hip, elbow, acromion - 50% 
5. Cervical spine - 40% 
6. Temperomandibular and Sternomastoidjoints - 30% 
7. Cricoarytenoid joint - 10% 
Diagnosis 
The revised criteria of 1987 (American college of Rheumatology) 
Criteria Comments 
1. Morning stiffness Duration > 1 hr lasting > 6 weeks 
2. Arthritis of atleast 3 areas Soft tissue swelling or exudation 
lasting > 6 weeks 
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3. Arthritis of hand joints Wrists, metacarpophalangeal 
joints or proximal interphalangeal joints 
lasting > 6 weeks 
4. Systemic Arthritis At  least one  area, lasting > 6 
weeks 
5. Rheumatoid Nodules As observed by the physician 
6. Serum Rheumatoid factor As assessed by a method positive in less 
than 5 percent of control 
subjects. 
7. Radiographic changes As seen on anteroposterior films 
of wrists and hands 
 
Rheumatoid arthritis is diagnosed if 4 of the 7 criteria are met. 
 
DISEASE PREVALENCE AND ONSET 
  Rheumatoid arthritis may occur at any age but has a  peak   incidence in the 
fifth decade. The lifetime incidence of the disease in women (1.8 per cent) is three 
times  more than in  males (0.5 per  cent)  and the prevalence of the disease in women 
over 65 years  old is  more than 5 per cent. The sex  difference is  most pronounced 
(as  high as  6:1) in those with early onset disease but is almost equal by the age of 65. 
The disease starts twice as commonly in winter. 
Explosive onset 
  In about 10 per cent of cases the onset of the disease is very rapid even 
overnight, with severe symmetrical polyarticular involvement. 
Systemic onset 
  This is particularly common in middle-aged men in whom non- articular 
feature may dominate the clinical picture. Fever, myalgia,  weight loss, anaemia, 
pleural effusions, and vasculitic lesions may be severe, sometimes in the absence of 
marked joint pathology. 
Insidious onset 
  The majority of cases of rheumatoid arthritis develop insidiously over weeks 
or months, with gradually increasing joint involvement seen in up to 70 per cent of 
cases. 
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Polymyalgic onset 
  Limb girdle muscle symptoms may precede the onset of arthropathy, 
particularly in the elderly. 
Mono-and pauci-articular onset 
  In young women  there  may initially be very limited joint involvement, 
particularly involving the knees. 
Joint features 
  Rheumatoid arthritis is typically a distal, symmetrical, small-joint polyarthritis 
involving the proximal interphalangeal and metacarpophalangeal joints of the  hands,  
the  wrists, metatarsophalangeal joints, ankles, knees, and cervical spine. The 
shoulders, elbows, and hips are less frequently involved, but can be a major source of 
morbidity. Any synovial joint in the body may be affected, including the 
cricoarytenoid and the temperomandibular joints. In addition, periarticular synovial 
structures, such as bursae and tendon sheaths, are commonly inflammed. 
The most common symptoms are pain and pronounced stiffness. The latter 
frequently exhibits a diurnal rhythm, worse on rising in the morning and then 
recurring towards the evening, perhaps reflecting the diurnal variation in plasma 
cortisol levels. 
  Gentle activity may alleviate the symptoms but is followed by stiffening or 
‘gelling’ with subsequent inactivity. The affected joints are frequently tender, swollen 
and warm and there may be limitation of both active and passive movement. Muscle 
wasting serves to accentuage the local swelling of the joint, which is in part due to 
proliferation of the synovial tissue and in part  to synovial effusion within the joint. 
Progressive destruction of the articular cartilage, subchondral bone, and periarticular 
soft tissues eventually combine to  produce  the characteristic deformities seen in 
long-standing rheumatoid arthritis. 
  In parallel with these clinical changes there are characteistic radiological 
appearance which may be helpful in the diagnosis of early rheumatoid arthritis and in 
monitoring its progress. In the early stages of the disease it is common for the first 
evidence of erosions to be  in  the feet. Diagnostic views in Radiological changes 
include: 
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1. soft-tissue swelling 
2. juxta-articular osteoporosis 
3. loss of joint space due to erosion of the articular cartilage 
4. bone erosions at the point of attachment of the synovium and 
5. joint deformities. 
 
Hands and wrists 
  The appearance of the hands in rheumatoid arthritis is highly characteristic. 
Early in the disease there may be soft-tissue swelling around the affected joints. 
Involvement of the proximal interphalangeal joints give a spindle-shaped 
appearance to the fingers, and soft-tissue swelling can be observed over the ulnar 
styloid, and in the second and third metacarpophalangeal joints. Distal interphalangeal 
joint involvement is less common (about 15 per cent of cases) but rheumatoid arthritis 
may sometimes be superimposed on  pre-existing osteoarthritis of these joints. 
  Tenosynovitis of the long flexor tendons in the palm of the hand may 
exacerbate stiffness of the finger and cause ‘trigger finger’. This may be associated 
with palpable crepitus over the tendon on active or passive movement of the 
corresponding finger. Similar synovitis at the wrist within the flexor retinaculum may 
cause compression of  the median nerve with the typical features of carpal tunnel 
syndrome - paresthesiae of the first three digits and the  radial  side  of  the  ring 
finger, wasting and weakness of the thenar mucles, with night pain frequently 
extending proximally as far as the elbow: typically these symtoms can be relieved by 
shaking the hand or  movement  of  the fingers. Tinel’s sign is sometimes positive but 
relatively insensitive. Phalen’s sign (pressure over the carpal tunnel with the wrist in 
flexion) may be more useful, not only because it is more frequently positive but also 
because it reproduces the symptoms accurately. The diagnosis can be confirmed if 
necessary by nerve conduction studies. 
  On the dorsal surface of the wrist, synovitis of  the  extensor  tendons is 
common and may lead to rupture. A ‘dropped finger’ affecting the little finger is an 
important indication for surgical exploration and synovectomy. 
  Bull’s horn deformity due to rupture of the extensor communis tendon from 
synovitis near the ulnar styloid. Selective sparing of the extensor indicis proprius and 
extensor digiti minimi tendons has in this instance preserved the ability to point the 
index and little finger independently 
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  Volar subluxation of the fingers at the metacarpophalangeal joints occurs 
as a result of destruction of the articular cartilage, and subsequent instability of these 
joints. Since the flexor tendons provide  the strongest force acting across these joints 
progressive subluxation towards the palm may develop, leaving the metacarpal heads 
relatively prominent. 
  Ulnar deviation and subluxation of the fingers as a result of instability of 
the metacarpophalangeal joints. The fingers may tend to drift in an ulnar direction 
because of the ulnar vector of  the  action of  both the flexor and extensor finger 
tendons. The process may be exacerbated by radial deviation of the carpus and also  
by ulnar subluxation of the extensor tendons if the support which usually hold them in 
place over the centre of the metacarpophalangeal joints are weakened by synovitis. 
  Swan neck deformities occur following volar subluxation of the proximal 
phalanges at the metacarpophalangeal joints, with subsequent contracture of the 
intrinsic muscles which become extensors rather than flexors of the proximal 
interphalangeal joints. Compensatory flexion of the distal interphalangeal joints 
occurs as  a  result of  a  tenodesis effect  as the flexor digitorum profundus tendon is 
stretched over  the hyperextended proximal interphalangeal joint. 
  Boutonniere (button-hole) deformity occurs when a chronic effusion within 
the proximal interphalangeal joint stretches or even ruptures the dorsal slip of  the 
extensor hood, allowing dorsal migration   of the joint  through the discontinuity. A 
similar process at the carpometacarpal joint of the thumb may give rise to the Z-
thumb deformity. 
  Piano-key sign can be detected when weakening of the distal radio-ulnar 
ligament by synovitis allows the distal ulna to migrate dorsally so that it overrides the 
radius (caput ulnae syndrome). The ulna can be depressed by pressure like a piano 
key (while the patient emits a note!). Progressive distruction of the carpal joints may 
be followed by volar subluxation and ultimately ankylosis. 
  Carpal collapse and fusion may accumulate in the disease, particularly in 
those with an early onset rheumatoid arthritis, when instability of the wrist may lead 
to collapse of the carpal bones, causing foreshortening of the carpus and, ultimately, 
spontaneous fusion of the wrist. 
Elbows and shoulders 
  Involvement of the elbows is less common than of the wrist but severe 
destruction may occur, leading to pronounced deformity and disability. 
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  The radiohumeral joint is more commonly symptomatic than the humero-ulnar 
joint and presents problems particularly with pronation / supination. Periarticular 
structures (olecranon bursa, ulnar nerve) may also affected by synovitis and 
subcutaneous  nodules are commonly found on the extensor surface of the forearm 
close to the elbow. 
  There may be inflammation of the subacromial bursa or supraspinatus tendon 
in addition to glenohumeral joint synovitis, producing a typical painful syndrome. 
Involvement of the acromioclavicular joint can give rise to pain particularly with 
overhead activities. 
Knees 
  Synovial proliferation is usually most obvious in the suprapatellar pouch and 
there may be pronounced wasting of the  quadriceps  as a result of reflex muscle 
inhibition. Synovial effusion typically produces posterior knee pain in the early stages 
by  stretching  the  posterior  capsule of the joint. This may lead to  the  development  
of a popliteal cyst communicating with the joint via a valve-like opening which  does 
not easily allow fluid back into the joint. Rupture of the joint or a  popliteal cyst may 
cause extravasation of highly irritant synovial fluid  into the calf where the 
inflammation and swelling may  mimic  a  deep  vein thrombosis. These two 
pathologies can sometimes coexist because there may be partial obstruction to  the 
venous return by the presence of  an extensive popliteal cyst. 
  Tricompartmental damage to the articular surfaces of the knees is the usual 
outcome of late disease and may cause severe instability of the joint as the collateral 
and cruciate ligaments become lax. Valgus deformities of the knees are the usual 
consequence of loading such unstable joints, and are often combined with a degree of 
fixed flexion deformity. Pain may also arise from periarticular structures, such as the 
insertion of the collateral ligaments which  are  chronically under  strain in the 
unstable knee joint. Even in the end stages of destruction of the knee joint. 
Hips 
  Involvement of the hips  in rheumatoid arthritis is relatively uncommon 
overall. Pain is usually experienced in the groin and the buttock but may radiate to the 
knee, sometimes mimicking  knee  arthritis. Rotation and abduction of the hip are  
reduced before flexion,  but ultimately fixed flexion deformity of the joint may occur. 
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AXIAL SKELETON 
  Involvement of the sacroiliac joints is rare in rheumatoid arthritis. Spinal 
arthritis is common, up to 80 per cent of patients demonstrating radiological evidence 
of the disease in the cervical spine. This may be asymptomatic but the most frequent 
result is painful limitation of movement, often in several planes. The most common 
radiological abnormalities consist of osteoporosis, erosion of the  zygopophyseal 
joints, erosions of the vertebral end plates, and loss of disc space in the absence of 
florid osteophytosis. 
  There may be evidence of atlantoaxial subluxation in up to 25 per cent of 
patients. Serious erosive change in the cervical spine is more likely in patients who 
have pronounced peripheral joint disease. 
Other joints 
  Hoarseness of the voice may occasionally be caused by effusion within the 
cricoarytenoid joints. Temporomandibular  joint  disease causes pain on chewing and 
may particularly restrict opening of the mouth. 
Rheumatoid nodules 
  Subcutaneous and intracutaneous nodules are a hallmark of the disease, 
occuring in about one-quarter of patients. They  are  discrete, firm, non-tender 
swellings varying from a new millimetres to several centimetres in size, and in rare 
instances, usually  seropositive males, they may occur in the absence of typical 
articular disease (rheumatoid nodulosis). They occur most frequently on the extensor 
surface of the forearm and olecranon, sites where repeated minor trauma from leaning 
could initiate their formation. They also commonly occur around tendons, including 
the Achilles, the flexor and extensor tendons of the fingers, and over the sacrum. 
Sometimes superficial nodules may break down with ulceration of the surrounding 
skin. 
  Histological examination of these nodules reveals central fibrinoid necrosis 
surrounded by palisades of fibroblasts and chronic inflammatory cells, suggesting a 
combination of proliferative and destructive tissue responses. Rheumatoid nodules 
may also develop in many other tissues including the eye (scleromalacia), pleura, 
pericardium, and parenchyma of the lungs and heart (where they may be found at 
autopsy in as many as 10 per cent of patients). They sometimes occur on the vocal 
cords and very occasionally they may cause dysfunction of the heart valves or 
conducting tissue. 
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Anaemia 
  A moderate normochromic normocytic anaemia is an almost invariable 
finding in active rheumatoid arthritis. In the chronic  anaemia of rheumatoid disease 
the blood picture is usually normocytic and normochromic or hypochromic (but  
rarely microcytic). Iron-binding capacity is typically reduced in active rheumatoid 
arthritis; normal or slightly raised levels in the presence of a low serum iron are 
therefore highly indicative of iron deficiency. In contrast, as part of  the  acute phase 
response, ferritin levels are typically elevated in active rheumatoid arthritis unless 
there is iron deficiency. The typical anaemia  of chronic disease seen in rheumatoid  
arthritis correlates closely with the sedimentation rate as a marker of disease activity 
and does  not respond to iron, folic acid or Vitamin B12. 
  Platelets:The platelet count is commonly increased increased to a level greater 
than 5 x 104 in active disease and  this  may  also  occur  when there is active 
bleeding from the intestine. 
Vasculitis 
  Vasculitis is more common in patients with high levels of IgM rheumatoid 
factor and severe joint disease, although the activity of the synovitis and extra-
articular disease is often temporally dissociated. Its incidence increase with the 
duration of the disease, but  occasionally it may be present from the outset, even 
rarely, in the absence of joint disease. 
  Rheumatoid vasculitis is associated with significant mortality but this can be 
significantly reduced with appropriate therapy. 
Lung involvement 
  Pleurisy has an incidence of about 1 per cent overall but pleural effusions due 
to rheumatoid arthritis may go undetected. Pleural involvement is five times more 
common in men than in women and often needs differentiation from other causes, 
particularly when other systemic features, such as weight loss and fever, are present. 
The fluid  has raised protein, low glucose, and low complement levels and is typically 
positive for rheumatoid factor. Pleural biopsy may reveal rheumatoid granulomata, 
like an ‘opened-out rheumatoid nodule’, but typically there is the appearance of 
non-specific  inflammation which does not allow differentiation from other causes of 
pleurisy. 
  Nodules are more common in the upper than the lower zones and may be 
single or multiple. Cavitation may  occasionaly lead to haemoptysis. Pulmonary 
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fibrosis is common in rheumatoid  arthritis but is often subclinical. Ten per cent of  
patients have radiological evidence of fibrosis and many more have evidence of 
impaired vital capacity and gas  transfer Classical fibrosing alveolitis occurs in  2  %  
of  patients  with rheumatoid arthritis and causes progressive, clubbing of  the  
fingers, fine late-inspiratory crepitations, and  lower-zone reticulonodular shadowing 
on the chest radiograph. 
  Obliterative bronchiolitis is a rare but rapidly progessive and fatal process 
manifesting with an acute onset of breathlessness. Widespread small airways 
obstruction is present in the absence of alveolar fibrosis and there is little evidence of 
inflammation. 
  Many patients with rheumatoid arthritis have evidence of airways obstruction 
irrespective of their smoking habits. Bronchiectasis also appears to be more common 
in those with the disease and to predate its onset. 
  Valvulitis may be apparent in 20 per cent of cases but is rarely symptomatic 
during life. Granulomatous thickening of the cusps of the aortic valve occurs more 
frequently than in the mitral valve but only produces incompetence of the valve. 
Acute  aortic  regurgitation  following perforation of one of the cusps is described. 
Autopsy studies reveal a patchy myocardial fibrosis in about one-sixth of patients and 
myocardial nodules can be found in some patients with small-vessel vasculitis. 
Myocardial infarction resulting from necrotizing vasculitis during life seems to be 
very low. 
Eyeinvolvement 
   This is common rheumatoid arthritis and may be due to localized tissue 
involvement or as part of  a  more  generalized disorder involving the exocrine glands 
- Sjogren’s syndrome. Exceptionally there may be diplopia resulting from stenosing 
tenosynovitis of the superior oblique tendon (Brown syndrome). 
  Sjogren’s syndrome is characterized by diffuse infiltration of the exocrine 
glands and other  tissues by lymphocytes, resulting  in destruction and glandular 
insufficiency. The syndrome occurs in  one- fifth of patients with rheumatoid arthritis 
(secondary  Sjogren’s syndrome) 
  Typical symptoms consist of pain, erythema and grittiness in the eyes, 
photosensitivity, and stickness associated with adherent strands of mucus. Secondary 
bacterial infection is relatively common due to  the  loss of lysozymes, bacteriostatic 
agents normally present in  tears.  Corneal damage may occur. 
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Extraglandular involvement is less common in secondary Sjogren’s syndrome than in 
the primary disease, but half of those with rheumatoid arthritis exhibit at least some 
degree of parotid gland enlargement. General malaise is common and cutaneous 
vasculitis, peripheral neuropathy, renal tubular acidosis, interstitial pulmonary 
fibrosis, and myositis may all coincide. 
  Episcleritis usually appears as a raised lesion in the anterior sclera with 
hyperaemia of the deeper layers. The lesions are often transient but may be associated 
with vasculitis. 
  Scleritis is less common but potentially more serious since it may lead to 
progressive thinning of the sclera (scleromalacia) and even perforation. Keratolysis 
(corneal melting) and limbal guttering are rare complications of vasculitis of the 
circumcorneal vessels which can also cause perforation. 
Peripheral nerve involvement 
  A mild glove and stocking sensory neuropathy  is  relatively common in 
rheumatoid arthritis but is usually benign and does not imply inflammation of nervous 
tissue. However, there may be lymphocytic infiltrates of the dorsal root ganglia in 
Sjogren’s syndrome. In contrast, the presence of a mixed  sensorymotor neuropathy or 
mononeuritis multiples is indicative of underlying vasculitis of the vasa nervorum. 
Muscle involvement 
  In rheumatoid arthritis muscle involvement is usually attributed to the reflex 
inhibition and wasting resulting from severe joint pain. Focal lymphocytic infiltration 
may be present on muscle biopsy, but its relevance to symptoms is in doubt and there 
is no increase in muscle enzyme concentrations in the serum to suggest active 
myositis. 
Liver involvement 
  This is evident in about 10 percent of patients with active disease. There may 
be mild hepatosplenomegaly and asymptomatic elevation  of the serum alkaline 
phosphatase. Minor degrees of fatty change, Kupffer cell hyperplasia, and 
lymphocytic infiltration of the poral tracts may be seen. 
The Felty syndrome 
  Lymphadenopathy is common in patients with  rheumatoid  arthritis, biopsies 
showing nodular hyperplasia. It is most obvious in patients with the Felty syndrome 
(rheumatoid arthritis, splenomegaly, 
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and leucopenia). Other extra-articular features are  frequently  present and include 
anaemia, thrombocytopenia, persistent vasculitic leg ulceration, cutaneous 
pigmentation, weight loss, and recurrent infection. It is uncommon (less than 1 per 
cent of all cases) and rarely develops in patients who have had the disease for less 
than 10 years. 
Investigation 
  No test is specific for diagnosiing Rheumatoid arthritis, 
A. Haematological: 
1. ESR - Increased in active stage. 
2. Serum proteins - Hyperglobulinaemia with elevation of Gamma and Alpha 2 
globulins hypoalbuminaemia during acute phase and C-reactive protien (CRP) 
WBC count is usually normal, but a mild leucocytosis may be present. Eosinophilia 
when present usually reflects severe systemic disease. 
B. Immunological: 
I. Rheumatoid Factor (RF): 
 Latex screening positive 
 Latex test positive 
 Sheep Caps Agglutination Test (Roose Waaler) (SCAT) 
 Differential Agglunination Test (DAT) 
 Human Erythrocyte Agglutination Test (HEAT) 
 
  Rheumatoid Factor (RF) is an auto antibody (Antibody directed against an 
organism’s own tissues). It is an antibody against the Fc  portion of IgG, which is 
itself an antibody. 
  Rheumatoid Factor (RF) is evaluated in patients suspected of having any form 
of arthritis even though positive results can be due to other causes, and negative 
results do not rule out the disease, but in combination with signs and symptoms. 
Immunological 
  The amount of Rheumatoid factor in blood can be measured by, 
 Agglutination Test: Blood is mixed with tiny rubber (latex) beads that are 
covered with human antibodies. If rheumatoid factor is present, the latex beads 
clump together (agglutinate). Normal Titre is 1:20 -  1:40 or  less Rheumatoid 
arthritis, titre  is greater than 1:20 - 1:40. 
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Auto antibodies other than Rheumatoid Factor in Rheumatoid Arthritis. 
 Antiperinuclear factor 
 Antikeratin antibodies 
 Antibodies to cyclic citrullinated peptide (CCP) 
 Antibodies to SA, p6 and calpastatin. 
  Of this Anti-CCP Antibodies stand out as the most useful clinically, especially 
in defining Rheumatoid arthritis in early stages. 
Rheumatoid Factor (RF) may also be elevated in 
Chronic hepatitis, Any chronic viral infection, Leukemia, Dermatomyositis, Systemic 
lupous erythematosus (SLE), Infectious mononucleosis and Systemic sclerosis. 
II. Anti Nuclear Antibodies: 
 Synovial fluid analysis  confirms  the  presence  of inflammatory arthritis. 
Fluid may show positive Roose - Waaler test in joint fluid, before it can be 
detected in blood. Also it may show neutrophils or monocytes inclusion 
bodies. 
III. Synovial biopsy: 
 Villus formation with thickening of synovial layer and infiltration with 
abnormal cells. 
IV. Radiographic Evaluation: 
 Soft tissue swelling 
 Juxta articular osteoporosis 
 Erosion of joints margins 
 Joint spaces are decreased 
 Deformities 
 Atlanto-axial subluxation 
 Subchondral erosions and cyst formation 
 Fibrous and bony ankylosis develops in the late stages. 
V. Arthroscopy: 
  In acute Rheumatoid Arthritis synovium is oedematous, diffusely 
erythematous and friable. In more chronic conditions it becomes thickened. 
VI. Renal Biopsy: 
  Indicated in cases of reduced tubular or glomerular function. 
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VII. Pulmonary Biopsy: 
  Used to distinguish Rheumatoid nodules from carcinoma or to establish 
diagnosis of fibrosing alveolitis. 
VIII. Ultra Sound 
IX. Scintigraphy 
X. CT Scanning 
  Shows cartilage and sub-chondral bone damage long before conventional                    
x rays. 
XI. MRI 
XII. Urine analysis 
XIII. Biochemical analysis XIV. Anti CCP antibodies 
  (Cyclic citrullinated peptide antibodies) 
XV. Genetic tests 
  HLADRB1 Typing to detect the presence of ‘Shared epitope’. 
XVI. Antinuclear antibody assay (ANA) 
XVII. Bone density test to check for bone loss 
Patients treated by simple methods show that after 10 years 50% will have 
improved and 50% deteriorated. Remissions of disease activity are most likely 
to occur during the first year. The median life expectancyof persons with 
Rheumatoid  arthritis is shortened by 3 to 7 years. 
 
DIFFERENTIAL DIAGNOSIS OF RHEUMATOID ARTHRITIS 
  Sero negative spondyloarthropathy included  following Rheumatoid like 
conditions were the serum is negative for Rheumatoid factor. They are, 
1. Ankylosing spondylitis: 
  Ankylosing spondylitis is a chronic, progressive and crippling disease 
affecting the spine. The exact etiology is unclear. Ankylosing spondylitis has been 
found to be more prevalent in certain races and  hence shows a genetic predisposition. 
It is related to certain tissue types of the human leukocytic antigen (HLA) system. The 
majority of ankylosing spondylitis patient is to belong to HLA-B27 groups. 
  The disease occurs in the 3rd and 4th decades of life and is more common in 
males. The patients present  with  complaints of  diffuse pain in the back and vague 
pain in other joints. 
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2. Reiter’s disease: 
  Reiter’s disease characterised by triad of polyarthritis, urethritis, 
conjunctivitis. The joint condition is an acute polyarthritis resembling Rheumatoid 
arthritis. It does not cause destructive changes in the joint structures. The urethritis is 
non-gonococcal but the exact  organism  is  not known. 
3. Psoriatic arthritis: 
  Psoriatic arthritis is a polyarthritis seen in about 10% of patients with 
psoriasis. 
 The most common type is the one involving the 
distal interphalangeal joints of the hands and feet  with psoriatic  nail joints. 
Metacarpophalangeal joints are never involved in psoriatic arthritis. 
 Arthritis multilens is a severe form where there is marked destruction of joints. 
 Symmetrical polyarthritic type 
 Oligo arthritic type 
 Spondyloarthritic type. 
1. Enteropathic arthritis: 
  Chronic inflammatory bowel disease like regional  enteritis (Crohn’s disease) 
and ulcerative colitis are associated with  arthritic lesion in about 10% of the cases. 
There is peripheral involvement of the spine. The joint condition shows remissions 
and  exacerbations  along with activity of the underlying bowel disease. 
2. Sjogren’s Syndrome: 
  Approximately 10 to 15% of patients with Rheumatoid arthritis, mostly 
women develop Sjogren’s syndrome, a chronic inflammatory disorder characterised 
by lymphocytic infiltration of lacrimal and  salivary glands. This leads to impaired 
secretion of saliva and tears and results in the sicca complex: dry mouth (xerostomia) 
and dry eyes (keratoconjunctivitis sicca). 
  Patients with Sjogren’s syndrome have a variable expression of disease in 
other exocrine glands. This is manifested clinically  as dry skin, decreased 
perspiration, dry vaginal membranes, or a nonproductive cough. 
  Commonly, there is also a polyclonal lymph proliferative reaction 
characterised by lymphadenopathy and spleenomegaly. This can mimic and rarely 
transform into a malignant lymphoma. 
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Clinical manifestations: 
 Keratoconjuctivitis and Xerostomia 
 Renal involvement produces mild interstitial  nephritis that may result in 
renal tubular acidosis. 
 Sensory polyneuropathy and mononeuritis multiplex. 
 Pulmonary involvement generally takes the form of an interstitial 
pneumonitis which is usually a little clinical significance. 
Complications 
1. Amyloidosis: 
  It is a complication of prolonged active disease and is formed in  25% to 35% 
of patients at autopsy, making Rheumatoid  Arthritis  a leading cause of secondary 
amyloidosis. 
2. Fixed deformities: 
  The perils often the common place ones resulting from ignorance and neglects. 
Early assessment and planning should prevent postural deformities that will result in 
joint contractures. 
3. Muscle weakness: 
  Even mild degree of myopathy or neuropathy when combined with prolonged 
inactivity may lead to profound muscle wasting and weakness. This should be 
prevented by physiotherapy and pain control if possible. 
4. Joint rupture: 
  Occasionally the joint lining ruptures and synovial contents spill into the soft 
tissue. 
5. Systemic vasculitis: 
  This is a rare but potentially serious complication. 
MANAGEMENT 
Treatment 
Treatment has five main aims. 
 Relief of pain 
 Reduction of inflammation 
 Minimizing undesirable side effects 
 Preservation of muscle strength and joint function 
 Return as rapidly as possible to a normal life style. 
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  A variety of physical therapy modalities may  be useful in decreasing the 
symptoms of Rheumatoid Arthritis.  Exercise is  directed  at maintaining muscle 
strength and joint mobility. 
Drug Therapy: 
The drugs used are as follows: 
1. Non-steroidal anti-imflammatory drugs (NSAIDs) 
2. Disease modifying antirheumatoid drugs (DMARDs) 
 Methotrexate 
 Gold 
 Penicillamine Antimalarials 
 Sulphasalazine 
3. Steriods 
4. Cytotoxic drugs 
 Azathioprine 
 Leflunomide 
 Cyclosporine 
 Cyclophosphamide 
5. Newer drugs 
 TNF receptor antogonist – etanarcept 
 TNF receptor antibody – infliximab 
 IL-1 receptor antagonist - anakinra 
Surgical Treatment 
 Synovectomy 
 Osteotomy 
 Arthroplasty 
 Excision arthroplasty 
 Replacement arthroplasty 
 Arthrodesis 
 Tendon transfer operation for correcting deformities 
 Excision of the metacarpophalangeal joints in case of gross deformities 
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4. MATERIALS AND METHODS 
 
 The Study on Uthiravatha Suronitham was carried out in the OPD and IPD of 
the Sirappu Maruthuvam department, Govt. Siddha Medical College, Palayamkottai.  
 The trial drugs used are Keelvayu nivarana chooranam (Internal) indicated 
in the authorised Siddha text  The pharmacopoeia of siddha research medicines  (Page 
No.183)  and Vathathirku  thylam (page No.83) (External) indicated in  Theraiyar 
vagadam for Uthiravatha Suronitham. 
 
OBJECTIVES: 
Primary objective: 
To evaluate the clinical efficacy of “KEELVAYU NIVARANA 
CHOORANAM ” (internal) & “VATHATHIRKU THYLAM” (external) in 
reducing the pain and restricted joint movements in the treatment of ‘Uthiravatha 
suronitham” (rheumatoid arthritis).  
 
Secondary objective: 
 To study the effect of Vedhu (steam bath) in reducing the pain towards the 
efficacy of medicine.  
 
Study design & conduct of study: 
Study type  : Phase II Criteria based open clinical trial 
Study place  : OPD & IPD of Govt Siddha Medical College & 
Hospital, Palayamkottai 
Study period  :     18 months 
Treatment : 
Internal medicine :  KEELVAYU NIVARANA CHOORANAM 
Reference   :  The Pharmacopoeia of siddha  
research medicines  Pg No:98  
Dose   :  10-20 grains(650mg- 1300mg), twice a day. 
Vehicle   :  - 
Duration   :  40 days  
External medicine :  VATHATHIRKU THYLAM 
Reference         : Theraiyar Vagadam  Pg.no 83  
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Subject selections: 
 Patients reporting with symptoms of inclusion criteria in P.G. Dept of 
Sirappumaruthuvam, GSMC, Palayamkottai will be subjected to screening test and 
documented using screening proforma. 
Inclusion criteria: 
• Age : 18-60 years 
• Sex : both male and female 
• Symmetrical joint involvement 
• Arthritis of 3 or more joints 
• Rheumatoid factor positive or negative 
• Morning stiffness 
• Swelling especially in the inter phalangeal joint. 
• Patients who are willing for admission and stay in IPD for 40 days or willing 
to attend OPD 
• Patient who is willing to undergo radiological investigation and give blood 
and urine samples for laboratory investigation. 
• Patient willing to sign the informed consent stating that he/she will 
consciously stick to the treatment during 40 days but can OPD out of the trial 
of his/her own conscious discretion. 
Exclusion criteria: 
• Systemic illness. 
• Pregnancy and lactation 
• History of trauma 
• Neurological disorder 
• Tubercular arthritis 
• Any other serious illness 
• Psoriatic arthritis 
• Gouty arthritis 
Withdrawal criteria: 
• Intolerance to the drug and development of adverse reactions during drug trial. 
• Poor patient compliance and defaulters. 
• Patient turned unwilling to continue in the course of clinical trial. 
• Occurrence of any adverse reactions.  
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Tests and assessment: 
A. Clinical assessment 
B. Routine investigations 
C. Specific investigations 
D. Radiological  investigations 
E. Siddha investigations  
A. Clinical assessment: 
• Arthritis involving three or more joints. 
• Symmetrical joint involvement 
• Morning stiffness 
• Anorexia 
• Spindle shaped appearance of fingers 
• Rheumatoid nodules 
• Depression 
• Distaste to food 
• Swelling of small joints of hands and foot. 
B. Routine investigation: 
Blood 
 Hb 
 Total WBC count 
 DC – 
1. Polymorphs 
1. Lymphocytes 
2. Eosinophils 
3. Monocytes 
4. Basophils 
Total RBC count 
ESR 
 ½ hr 
 1 hr 
Blood sugar  
 r: 
 f: 
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 pp: 
Serum cholesterol. 
Urine 
 Albumin  
Sugar  
Deposit 
C. Specific investigations 
 CRP 
 RA factor 
 ASO titer 
D. Radiological investigations: 
 X ray of affected joints (AP and lateral view) 
E. Investigation based on siddha system: 
1. Naa 
2. Niram 
3. Mozhi 
4. Vizhi 
5. Naadi 
6. Sparisam 
7. Malam 
8. Moothiram 
Conduction of the  study: 
                15ml of Vellai ennai is given in early morning, on the very first day of 
treatment for purgation. This will help to bring the vitiated mukkutram back to 
normal. From the next day, the trial drug is given for treatment.  
Then the trial drug KEELVAYU NIVARANA CHOORANAM (internal), 
VATHATHIRKU THYLAM (external) is given continuously for 40 days. OP 
patients should visit the hospital once in seven days.  At each clinical visit clinical 
assessment is done and prognosis is noted.  For IP patients the drug is given for 40 
days and the clinical assessment is done daily. 10 IP patients will be given Vedhu 
(steam bath) treatment along with their internal medicine. The remaining 10 IP 
patients will not be given Vedhu (steam bath). The results will be compared at the end 
of the study. Laboratory investigations & radiological investigation are done 0 day, 
20th day, 40th day of the trial. For IP patients, who are not in a situation to stay in the 
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hospital for a long time is advised to attend the OPD for further follow-up. After the 
end of the treatment, the patient is advised to visit the OPD for another 2 months for 
follow-up. If any trial patient who fails to collect the trial drug on the prescribed day 
but wants to continue in the trial from the next day , he/she will be allowed, but 
defaulters of one week and more will not be allowed to continue and be withdrawn 
from the study with a fresh case being included. 
 
Outcome:  
 
 The outcome is aimed at reducing the pain and weakness. 
Universal pain assessment scale 
A.   0      :  no pain 
B.   1 -3 : mild pain 
C.   4-6 : moderatepain 
D.  7-10 : severepain 
Reference: clinical manual for nursing practice. (National institute of health warren 
grant magnuson clinical center)  Restricted movements is assessed by  
Gradation of restricted movements: 
• G i – able to perform normal duties 
• G ii – moderate restriction – self care is possible. 
• G iii – marked restriction – limited self care / some assistance required. 
• G iv – confined to bed or wheel chair.  
Adverse effect/serious effect management 
     If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and proper management will be given in OPD of Govt. 
Siddha medical college and hospital, Palayamkottai. 
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4. RESULTS AND OBSERVATION 
 For the clinical study 40 patients were selected and treated in PG-III 
SirappuMaruthuvam Department, Government Siddha Medical College and Hospital, 
Palayamkottai. Results were observed with respect to the following criteria. 
1. Gender distribution 
2. Age distribution 
3. Kaalam 
4. Occupation 
5. Seasonal Variations 
6. Thinai 
7. Socio-economic status 
8. Directory habits 
9. Mode of onset 
10. Duration of conditions 
11. Clinical symptoms 
12. Deformity 
13. Involvement of joints 
14. Conflict in Kanmathiriam 
15. Disturbance in Vatham 
16. Disturbance in Pitham 
17. Disturbance in Kabam 
18. Disturbance in UdalKattugal 
19. Envagaithervugal 
20. Naadi 
21. Neikuri 
22. Assessment of results by the effect of conbined therapy. 
    
 
 
 
 
 
 
 1. GENERAL DISTRIBUTION
S.No Gender
1 male
2 female
 Total
 
   
 
Inference: 
 Among 40 patients selected for this study. 85% are female and 15% are male.
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Table : 1 
 
 No. of Cases Percentage (%)
 6 
 34 
 40 
      
 
female
 
15 
85 
100 
 
 
Column2
female
 2. AGE DISTRIBUTION
S.No. Age Year
1 30-40
2 41-50
3 51-60
 Total
 
   
 
Inference: 
 The prevalence of the diseases is found to be higher in the age group of 51
years(42.5%). 
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Table : 2 
 No. of Cases Percentage (%)
 10 
 13 
 17 
 40 
  
 
41-50 51-60
 
25 
32.5 
42.5 
100 
 
-60 
51-60
41-50
30-40
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3. KAALAM 
Table : 3 
 
 S.No. Kaalam 
No. of 
Cases 
Percentage 
(%) 
1 Vathakaalam (upto 33yrs) 3 7.5 
2 
Pithakabalamupto 
(33 years & 66 years) 
37 92.5 
3 Kabhakaalam (Above 66 years) 0 0 
 TOTAL 40 100 
 
      
 
 
 
Inference: 
 Out of 40 cases, 92.5% of cases were founded to be in pithakaalam. 7.5% of 
cases were found to be in Vadhakaalam. 
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 4. OCCUPATION 
S.No. 
1 Farmer and Labour
2 Carpenter / Mason
3 Teacher 
4 Housewife
5 House keeper
6 Tailor 
 Total 
 
   
 
Inference: 
Out of 40 cases, in this study the rate of incidence is higher in 
which includes House Wife 72.5%,Farmers and Labour 15%,  Teachers 7.5% and 
Tailor 5%. 
59 
Table : 4 
 
Occupation 
No. of 
Cases 
 6 
 0 
3 
 29 
 0 
2 
40 
  
occupational group 
Percentage 
(%) 
15 
0 
7.5 
29.5 
0 
5 
100 
 
Farmer and Labour
Carpenter / Mason
Teacher
Housewife
House keeper
Tailor
  
5. SEASONAL VARIATIONS
S.No. 
1 Kaarkaalam ( Age 16 
2 Koothirkaalam (oct 16 
3 Munpanikaalam (dec 16 
4 Pinpanikaalam (feb 16 
5 Ilavenirkaalam (Apr 16 
6 Muthuvenikaalam (Jun 16 
 Total 
 
Inference: 
 Out of 40 cases, 37.5 patients were admitted in munpanikaalam, 22.5% of 
patients were admitted in pinpanikaalam, 20% of patients were admitted 
inmuthuvenilkaalum, 12.5% of patients were admitted in Kaarkaalam, 7.5% of 
patients were admitted in munpanikaalu
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Table : 5 
 
Seasons 
No. of 
Cases 
- Oct 15) 5 
- dec 15) 3 
- Feb 15) 15 
- Apr 15) 9 
- Jun 15) 0 
- Aug 15) 8 
40 
m.  
Percentage 
(%) 
12.5 
7.5 
 
37.5 
22.5 
0 
20 
100 
 
61 
 
6. THINAI 
Table : 6 
 
S.No. Seasons 
No. of 
Cases 
Percentage 
(%) 
1 Kurinji (Hill area) 0 0 
2 Mullai (Forest area) 0 0 
3 Marutham (Fertile area) 32 80 
4 Neithal (Coastal area) 8 20 
5 Paalai (Desert land) 0 0 
 TOTAL 40 100 
 
     
 
Inference: 
 Among 40 cases, majority were from MaruthaNilam (80% 
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 7. SOCIO ECONOMIC STATUS
S.No. Class 
1 Rich 
2 Middle class
3 Poor 
 Total 
 
 
 
Inference: 
 Out of 40 cases, 57.5% cases were from poor 
cases from middle class and only 5% of cases from Rich background.
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Table : 7 
 
No. of 
Cases 
2 
 15 
23 
40 
socio-economic status, 37.5% of 
 
Middle class Poor
Percentage 
(%) 
5 
37.5 
57.5 
100 
 
 
Poor
Middle class
Rich
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8. DIETARY HABITS 
Table : 8 
 
S.No. Dietary 
No. of 
Cases 
Percentage 
(%) 
1 Vegetarian 5 12.5 
2 Non-vegetarian 35 87.5 
 TOTAL 40 100 
 
 
 
 
Inference: 
 Most of the cases have non-vegetarian diet habit (87.5%) 
 
 
 
  
Dietary
Vegetarian
Non-vegetarian
 9.MODE OF ONSET:
S.No. Mode of Onset
1 Acute 
2 Gradual 
 Total 
     Fig 5.9 
Inference: 
 According to this study 75% of the cases 
disease. 
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Table : 9 
 
 
No. of 
Cases 
10 
30 
40 
were reported gradual onset of 
 
mode of onset
Percentage 
(%) 
25 
75 
100 
 
Acute
Gradual
 10. DURATION OF CONDITIONS:
S.NO Duration (Months)
1 0-3 
2 4-6 
3 7-12 
4 13-24 
5 Above 24
 Total 
 
 
Inference: 
 Among the 40 cases, 14 cases (35%) were come under 0
(40%) were come under 4
7 cases (17.55%) were come under 13
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Table : 10 
 
 
No. of 
Cases 
14 
16 
3 
7 
 0 
40 
-3 months, 16 cases 
-6 months, 3 cases (7.5%) were come under 7
-24 months 
Duration (Months)
Percentage 
(%) 
35 
40 
7.5 
17.5 
0 
100 
 
-12 months,             
0-3
6-Apr
12-Jul
13-24
Above 24
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11. CLINICAL SYMPTOMS (BEFORE AND AFTER TREATMENT) 
Table : 11 
 
S. 
No 
Clinical 
features 
Before 
treatment 
After treatment 
No. of 
cases 
% Releived % Reduced % No 
improvement 
% 
1. Pain 40 100 8 20 30 75 2 5 
2. Swelling of 
joints 
40 100 8 20 32 80 0 0 
3. Morning 
stiffness 
40 100 8 20 30 75 2 5 
4. Tenderness 40 100 4 10 36 90 0 0 
5. Restricted 
movements 
40 100 2 5 38 95 0 0 
6. Warmth 40 100 2 5 38 95 0 0 
7. Low grade 
fever 
15 40 15 100 0 0 0 0 
8. Sleeplessness 30 75 30 100 0 0 0 0 
9. Loss of 
appetite 
15 37.5 15 100 0 0 0 0 
 
 
Inference:  
  Pain, swelling of joints,  morning stiffness, tenderness, restricted movement 
and warmth were found in all the 40 patients before treatment. 
After treatment there was a considerable reduction in all symptoms particularly in 
pain, morning stiffness, swelling of joints, tenderness, restricted movements and 
warmth. 
 After treatment there was a complete relief in the symptoms like low grade 
fever, sleeplessness and loss of appetite. 
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CLINICAL FEATURES
 12. DEFORMITIES 
 
S.No. Deformity 
1. Spindle shaped fingers
2. Swan neck 
3. Z shaped 
4. Ulnar deviation of hand
5. Hallus valgus 
 
 
Observation 
 Among the 40 patients,22.5% cases hand spindle shaped fingers, 12.5% cases 
had ulnar deviation of hand,2.5% 
deformity,and 2.5 cases had z shaped deformity.
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Table : 12 
Number of cases 
 9 
4 
1 
 5 
1 
cases had hallusvalgus ,10% cases had swan neck 
 
Z shaped Ulnar 
deviation 
of hand
Hallus 
valgus
Hallus valgus
Ulnar deviation of hand
Z shaped 
Swan neck
Spindle shaped fingers
Percentage 
22.5 
10 
2.5 
12.5 
2.5 
 
 13: INVOLVEMENT OF JOINTS
 
S.No. Joints involved
1. Proximal interphalangeal joints of 
2. Metacarphphalangeal joints
3. Wrist joints 
4. Elbow joints 
5. Shoulder joints
6. Cervical spine 
7. Hip joints 
8. Knee joints 
9. Ankle joints 
10. Metatarsophalangeal joints
 
 
  Among the 40 cases 95% had knee joints, 95% of the cases had proximal 
interphalangeal joint,87.5% had  ankle joints, and  82.5% metacarpophalangeal joints, 
62.5% had wrist joints, 45% had cervical spine, 40% had elbows, 25% had hip joints, 
17.5 %had shoulder joi
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Table : 13 
 Number of cases 
38 
 33 
25 
16 
 7 
18 
10 
38 
35 
 20 
nts and 50% had meta tarsophalangea 
Percentage 
95 
82.5 
62.5 
40 
17.5 
45 
25 
95 
87.5 
50 
 
 14. CONFLICT IN KANMENTHIRIAM:
S.No. Kanmenthiriam
1 Vaai 
2 Kai 
3 Kaal 
4 Eruvai 
5 Karuvai
 
 
 
 
Inference: 
 Among all the 
Kaal were affected in all 40 cases (100%) and Eruvai was affected in 8 cases (20%)
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Table : 14 
 
No. of 
Cases 
0 
40 
40 
8 
 0 
TOTAL 40 
Kanmenthiriam (Vaai, Kai, Kaal, Kruvai, Karuvai)Kai and 
Kanmenthiriam
Percentage 
(%) 
0 
100 
100 
20 
0 
100 
 
 
Vaai
Kai
Kaal
Eruvai
Karuvai
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15: DISTURBANCES IN VATHAM: 
Table : 15 
 
S.No. Vatham 
No. of 
Cases 
Percentage 
(%) 
1 Pranan 20 50 
2 Abanan 8 20 
3 Udhanan 21 52.5 
4 Viyanan 40 100 
5 Samanan 40 100 
6 Nagan 5 12.5 
7 Koorman 0 0 
8 Kirukaran 9 22.5 
9 Devathathan 9 22.5 
10 Dhananjeyan 0 0 
 
 
Inferences: 
 Viyanan and Samanan were affected in all the 40 cases (100%), Udhanan were 
affected in 21 cases(52.5%), pranan were affected in 20 cases (50%) Abanan were 
affected in 8 cases (20%) Kirukaran and Devathathan affected in 9 cases (22.5%) 
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16.DISTURBANCES IN PITHAM 
Table : 16 
 
S.No. Duration (Months) No. of 
Cases 
Percentage 
(%) 
1 AnarPitham 10 25 
2 RanjagaPitham 12 30 
3 SathagaPitham 40 100 
4 PrasagaPitham 0 0 
5 AlosagaPitham 1 2.5 
 
 
 
 
Inference: 
 SathgaPitham was affected in all the 40 cases (100%) Ranjagapitham was 
affected in 12 cases (30%), Anarpitham was affected in 10 cases (25%) Alosagam 
was affected in I case(2.5%) 
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17. DISTURBANCE OF KABAM: 
Table : 17 
 
S.No. kabam 
No. of 
Cases 
Percentage 
(%) 
1 Avalambagam 40 100 
2 Kilathagam 0 0 
3 Bothagam 0 0 
4 Tharpagam 0 0 
5 Santhigam 40 100 
 
 
 
Inference: 
 Among all Santhigam and Avalambagam was affected in all 40 cases (100%) 
Kabam
Avalambagam
Kilathagam
Bothagam
Tharpagam
Santhigam
 18.DISTURBANCE IN UDAL KATTUGAL:
 
S.No. UdalKattugal
1 Saaram 
2 Seneer 
3 Qon 
4 Kozhuppu
5 Enbu 
6 Moolai 
7 Sukilam / 
 
 
Inference: 
 It was diagnosed, during the study that among the seven udalkattukal, Saaram, 
oon, Kozhuppu, Enbu,moolaiwere affected in 40 cases (100%) 
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Table : 18 
 
No. of 
cases 
40 
10 
3 
 40 
20 
0 
Surondidham 0 
 
 
25
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Qon Kozhuppu Enbu Moolai
UDAL KATTUGAL
Percentage 
(%) 
100 
25 
7.5 
100 
50 
0 
0 
 
0 0
Sukilam / 
Surondidham
 19.DISTURBANCE IN ENVAGAI THERVUGAL:
S.No. 
1 Naa 
2 Niram 
3 Mozhi 
4 Vizhi 
5 Malam 
6 Moothiram
7 Sparisum
8 Naadi 
 
 
Inference: 
 It was learnt during the study that Naadi was noted in all 40 cases (100%) 
Malam was affected in 8 cases (20%)
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Table:19 
Envagai Thervugal 
No. of 
Cases 
0 
0 
0 
0 
8 
 0 
 0 
40 
 
 
Envagai Thervu
Percentage 
(%) 
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20 
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0 
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 20.PULSE READING (NAADI)
 
S.No. 
1 Vathapitham
2 Pithavatham
3 Kabavatham
 
 
Inference: 
 As mentioned above naadi was noted in all cases and among that 20 cases 
(50%) were vathapitham, 14 cases(35%) were pithavatham, and remaining 6 cases 
(15%) were kabavathanaadi.
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Table : 20 
Parameters 
No. of 
Cases 
 20 
 14 
 6 
 
 
Pithavatham Kabavatham
Percentage 
(%) 
50 
 
35 
15 
 
Kabavatham
Pithavatham
Vathapitham
 21. NEIKURI 
 
S.No. 
1 Spreading like snake (vathaneer)
2 Spreading like aring (pithaneer)
3 Stands like a pearl (kabaneer)
4 Combination of ring and snake
 
 
 
Inference: 
 In Neikuri analysis, 67.5% of the cases presented with Vathaneer, 15% with 
pithaneer 17.5% with kabaneer.
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Table : 21 
Inference 
No. of 
Cases 
 27 
 6 
 7 
 0 
 
Spreading like 
aring (pitha 
neer)
Stands like a 
pearl (kaba 
neer)
Combination of 
ring and snake
15
17.5
0
Percentage 
(%) 
67.5 
15 
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0 
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22:ASSESSMENT OF RESULT BY THE EFFECT OF COMBINED 
THERAPY 
Table : 22 
 
S.No. Effect of therapy No of patients Percentage (%) 
1 Marked effect 25 62.5 
2 Moderate effect 10 25 
3 Mild effect 5 12.5 
4 No effect 0 0 
 
 
 
Inference: 
 Thus from the analysis of the data collected during the course of treatment and 
at the end of treatment it is inferred that the overall effect of the therapy. Internal, 
external and complementary. Marked effect of 62.5% moderate effect of 25% and 
mild effect of 12.5%. 
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Table: 23.(a) List of  Out Patients of PG-III Sirappu Maruthuvam Department Given 
1. Keel vayu nivarana chooranum- Internal 2. Vathathirku thylam - External 
S.NO OP.NO NAME AGE/SEX 
Date of 
Registration 
on 
Date of 
Discharge 
Total 
No.of 
days 
treated 
Symptoms 
RESULTS 
P S MS MR 
1 56809 Sivagami 40/F 07/07/2018 20/08/2018 45 + + + + Good 
2 62837 larence 44/M 28/7/2018 06/11/2018 40 + + + + Moderate 
3 63450 Nurjagan 40/F 31/7/2018 08/09/2018 40 + + + + Moderate 
4 65529 Lakshmi 50/F 06/08/2018 28/09/2018 55 + + + + Fair 
5 69339 Muthulakshmi 50/F 21/08/2018 06/10/2018 47 + + + + Good 
6 78021 Murugan 30/M 20/09/2018 31/10/10 42  + + + Good 
7 107638 Alagammal 53/F 28/12/2018 01/02/2019 36 + + + + Good 
8 8647 Jayalakshmi 55/F 23/01/2019 05/03/2019 42 + + + + Moderate 
9 9146 Rathinum 55/F 24/01/2019 20/03/2019 56 + + + + Mild 
10 13816 Sanmugamuthu 45/F 07/02/2019 14/03/2019 36 + + + + Moderate 
11 16298 Isaaik 35/M 13/02/2019 23/03/2019 40 + + + + Good 
12 16664 Saresvathi 60/F 14/12/2019 30/03/2019 45 + + + + Moderate 
13 17966 Muthulakshmi 45/F 16/02/2019 30/03/2019 43 + + + + Moderate 
14 18236 Prama 47/F 19/02/2019 03/04/2019 44 + + + + Good 
15 20131 Kamala 52/F 25/02/2019 05/04/2019 40 + + + + Good 
16 22128 Jancie 38/F 02/03/2019 10/04/2017 40 + + + + Mild 
17 27501 Vadivu 52/F 19/03/19 05/05/2019 48 + + + + Moderate 
18 27602 Mariappa 58/M 19/03/2019 31/04/2019 43 + + + + Good 
19 30036 Rajammal 34/F 27/03/2019 14/05/2019 48 + + + + Moderate 
20 31799 Chellammal 45/F 02/04/2019 08/05/2019 37 + + + + Moderte 
P- Pain, S – Swelling, MS – Morning stiffness, MR – Movement Restricted 
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Table 25 (b)  Investigation for OP Patients 
S.No OP.No 
Haemotological Investigation 
  
Urine Analysis 
WBC Total WBC Differential Count (%) E.S.R. mm/hr HB (gms%) BT AT RA FACTOR BT AT mgs% mgs% 
BT AT 
BT AT BT AT 
BT AT BS BU BC BS BU BC BT AT Alb Sug Dep Alb Sug Dep P L E P L E 1/2 hr 1 hr 
1/2 
hr 
1 
hr 
1 56809 6000 6200 64 34 2 66 32 2 15 30 15 28 11 12 80 31 102 90 23 106  +  + Nil Nil NAD Nil Nil NAD 
2 62837 8200 8600 72 24 4 72 26 2 27 45 20 42 10.5 11 90 19 162 90 19 158  +  + Nil Nil 
1-2 
PC Nil Nil NAD 
3 63450 9500 9400 62 34 4 63 34 3 26 40 25 38 9.8 10.5 80 28 199 80 22 195  +  + Nil Nil NAD Nil Nil NAD 
4 65529 8000 8100 61 33 6 61 34 5 13 44 12 42 9 10.5 109 20 141 105 17 150  +  + Nil Nil NAD Nil Nil NAD 
5 69339 10000 9900 65 34 1 67 33 - 18 40 22 58 9.9 10.5 90 25 126 90 19 120  +  + Nil Nil NAD Nil Nil NAD 
6 78021 8100 8300 73 20 7 74 22 4 80 120 65 90 9.9 11 88 17 198 92 16 194  +  + Nil Nil NAD Nil Nil NAD 
7 107638 11000 11000 50 36 4 60 37 3 20  44 16 38 11.2 11.4 100 12 121 96 15 121  +  + Nil Nil NAD Nil Nil NAD 
8 8647 8800 8400 66 29 5 65 30 5 25 41 24 35 10.4 11.5 108 28 132 108 27 133  +  + Nil Nil NAD Nil Nil NAD 
9 9146 8700 8700 76 23 1 76 23 1 28 45 18 40 8.9 10.6 90 13 137 92 14 135  +  + TRACE Nil 
1-2 
PC Nil Nil NAD 
10 13816 7000 7200 68 30 2 67 30 3 45 76 42 72 9.3 10.4 106 21 144 102 19 145  +  + Nil Nil 
1-2 
PC Nil Nil NAD 
11 16298 7500 7800 70 30 - 66 33 1 10 20 6 14 11.5 11.5 112 19 168 110 17 162  +  + Nil Nil NAD Nil Nil NAD 
12 16664 9500 9600 62 36 2 63 34 3 8 10 10 20 12 12.5 80 26 164 82 24 156  +  + Nil Nil NAD Nil Nil NAD 
13 17966 7000 7100 69 28 3 72 27 1 20 38 18 38 11 11.4 82 18 130 90 20 128  +  + Nil Nil NAD Nil Nil NAD 
14 18236 9000 9200 65 30 5 64 31 5 30 54 28 48 11.5 12 109 16 150 107 17 157  +  + Nil Nil NAD Nil Nil NAD 
15 20131 7800 8000 70 26 4 72 25 3 20 60 18 55 9.9 11 96 26 152 88 18 145  +  + TRACE Nil NAD Nil Nil NAD 
16 22128 8600 8400 73 25 2 70 24 6 33 40 31 38 11 11.5 110 20 160 109 22 140  +  + Nil Nil NAD Nil Nil NAD 
17 27501 7000 7200 65 32 3 68 28 4 22 41 20 40 12 13 86 28 152 90 25 138  +  + Nil Nil NAD Nil Nil NAD 
18 27602 8100 8200 70 26 4 68 26 6 30 60 26 59 12.5 13 94 24 152 100 22 150  +  + Nil Nil NAD Nil Nil NAD 
19 30036 9100 9000 63 35 2 70 30 - 17 40 13 35 11.8 12.2 101 21 160 105 22 160  +  + Nil Nil 
1-2 
PC Nil Nil NAD 
20 31799 8900 8800 63 30 7 62 36 2 18 42 16 36 10.8 11.5 100 14 187 95 20 160  +  + Nil Nil 
1-2 
PC Nil Nil NAD 
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Table: 26 (a)  List of  IN Patients of PG-III Sirappu Maruthuvam Department Given 
1. Keel vayu nivarana chooranum- Internal 2. Vathathirku thylam - External 
 
S.NO IP.NO NAME AGE/SEX D.O.A D.O.D NO.OF. DAYS 
SYMPTOMS RESULT 
P S MS MR 
1 1720 Mariammal 48/F 06/07/2018 21/08/2018 47 + + + + G00D 
2 1759 Bearmugamath 52/M 10/07/2018 17/08/2018 39 + + + + MODERATE 
3 1897 Lakshmi 60/F 25/07/2018 21/09/2018 40 + + + + MODERATE 
4 1981 Pappa 55/F 03/08/2018 21/09/2018 32 + + + + GOOD 
5 2044 Kiruba 53/F 09/08/2018 03/09/2018 26 + + + + GOOD 
6 2189 Sankaravadivu 37/F 27/08/2018 09/10/2018 44 + + + + MILD 
7 2239 Abrin 40/F 31/08/2018 05/10/2018 36 + + + + GOOD 
8 2913 Esakkiammal 31/F 28/11/2018 29/12/2018 32 + + + + GOOD 
9 2968 Gomathi 55/F 05/12/2018 04/01/2019 32 + + + + MODERATE 
10 13 Kannammal 50/F 03/01/2019 18/02/2019 48 + + + + FAIR 
11 151 Velammal 57/F 24/01/2019 21/02/2019` 29 + + + + MILD 
12 507 Pacheammal 33/F 27/01/2019 13/03/2019 46 + + + + MODERATE 
13 249 Krishanaammal 46/F 05/02/2019 13/03/2019 37 + + + + MODERATE 
14 261 Krish 60/F 06/02/2019 25/03/2019 49 + + + + MODERATE 
15 275 Kalaiselvi 47/F 07/02/2019 20/03/2019 42 + + + + GOOD 
16 359 Saresvathi 60/F 13/02/2019 29/03/2019 46 + + + + GOOD 
17 367 Ramalakshmi 43/F 14/02/2019 29/03/2019 45 + + + + MILD 
18 466 Aarumugam 60/F 23/02/2019 27/03/2019 36 + + + + MILD 
19 490 Pakiyavathi 41/F 26/02/2019 23/03/2019 26 + + + + GOOD 
20 513 Guruswamy 59/M 28/02/2019 09/04/2019 40 + + + + GOOD 
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Table 26 (b) Investigation for IP Patients 
S.No 
IP.No 
Haemotological Investigation 
  
Urine Analysis 
WBC Total WBC Differential Count (%) E.S.R. mm/hr 
HB 
(gms%) 
BT AT RA 
FACTOR BT AT mgs% mgs% 
BT AT 
BT AT BT AT 
BT AT BS BU BC BS BU BC BT AT Alb Sug Dep Alb Sug 
Dep P L E P L E 
1/2 
hr 
1 
hr 
1/2 
hr 
1 
hr 
1 1720 6200 6200 64 32 4 66 32 2 15 30 15 28 11 12 80 31 108 90 24 106  +  + TRACE Nil NIL Nil Nil NAD 
2 1759 8200 8600 72 24 4 72 26 2 27 45 20 42 10.5 11 90 19 13 100 20 158  +  + Nil Nil NIL Nil Nil NAD 
3 1897 9500 9000 66 34 0 63 37 0 26 40 25 38 9.8 10.5 80 28 199 80 22 195  +  + Nil Nil 1-2 PC Nil Nil NAD 
4 1981 8000 8100 61 33 6 61 35 4 13 44 12 42 9 10.5 109 20 141 105 17 150  +  + Nil Nil NIL Nil Nil NAD 
5 2044 10000 9900 65 34 1 67 33 - 18 40 22 58 9.9 10.5 90 25 126 90 19 120  +  + TRACE Nil 1-2 PC Nil Nil NAD 
6 2189 8100 8200 73 20 7 74 22 4 80 120 65 90 9.9 11 88 17 198 92 16 194  +  + Nil Nil NIL Nil Nil NAD 
7 2239 11000 11000 50 36 4 60 37 3 20  44 14 36 11.2 11.4 100 12 121 98 15 121  +  + Nil Nil NIL Nil Nil NAD 
8 2913 8800 8400 66 29 5 65 30 5 25 41 24 35 10.4 11.5 108 28 140 118 27 133  +  + Nil Nil NIL Nil Nil NAD 
9 2968 8700 9000 75 24 1 77 24 1 28 40 18 38 8.9 10.6 90 13 137 92 14 135  +  + Nil Nil 1-2 PC Nil Nil NAD 
10 13 7000 7200 68 30 2 67 30 3 45 76 42 72 9.3 10.4 106 21 144 102 19 145  +  + Nil Nil NIL Nil Nil NAD 
11 151 7500 7800 70 30 - 66 33 1 10 20 6 14 11.5 11.5 112 19 168 110 17 162  +  + TRACE Nil 1-2 PC Nil Nil NAD 
12 507 9500 9600 62 36 2 63 34 3 8 10 10 20 12 12.5 80 26 164 82 24 156  +  + Nil Nil 1-2 PC Nil Nil NAD 
13 249 7000 7100 69 28 3 72 27 1 20 38 18 38 11 11.4 82 18 130 90 20 128  +  + Nil Nil 1-2 PC Nil Nil NAD 
14 261 9000 9200 65 30 5 64 31 5 30 54 28 48 11.5 12 109 16 150 107 17 157  +  + Nil Nil 1-2 PC Nil Nil NAD 
15 275 7800 8000 70 26 4 72 25 3 20 60 18 55 9.9 11 96 26 152 88 18 145  +  + TRACE Nil 1-2 PC Nil Nil NAD 
16 359 8600 8400 73 25 2 70 24 6 33 40 31 38 11 11.5 110 20 160 109 22 140  +  + Nil Nil 1-2 PC Nil Nil NAD 
17 367 7000 7200 65 32 3 68 28 4 22 41 20 40 12 13 86 28 152 90 25 138  +  + Nil Nil 1-2 PC Nil Nil NAD 
18 466 8100 8200 70 26 4 68 26 6 30 60 26 59 12.5 13 94 24 152 100 22 150  +  + Nil Nil 1-2 PC Nil Nil NAD 
19 490 9100 9200 64 34 2 70 30 - 15 38 13 35 11.8 12.2 101 21 160 105 22 146  +  + Nil Nil 1-2 PC Nil Nil NAD 
20 513 8900 8800 63 30 7 62 36 2 18 42 16 34 10 11 101 16 188 96 26 168  +  + Nil Nil 1-2 PC Nil Nil NAD 
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6. DISCUSSION 
 
The main aim of the treatment was to study the Therapeutic effect of the drug KEEL 
VAYU NIVARANA CHOORANAM (internal),VATHATHIRKU THYLAM (External) and 
VEDHU (external therapy) as compained therapy  to reduce pain, swelling and restricted 
joint movements in the disease Uthira Vatha Suronitham. The clinical features of Uthiravatha 
Suronitham can be correlated to Rheumatoid Arthritis in modern science. Rheumatoid 
Arthritis is a chronic inflammatory, destructive, and deforming symmetrical poly arthritis 
associated with symmetrical involvement of joints. 
            Uthiravatha Suronitham is a Vatha disease in which, there occur a derangement of 
Vatha thathu and Pitha thathu.  
Gender Distribution 
 From the above tabulation. Among the 40 patients selected,85% were female, and 
15% were female. 
Age distribution 
 Among the 40 patients selected this study shows high incidence of UTHIRA 
VAATHA SURONITHAM (RHEUMATOIDARTHRITIS) was in above 51-60years 
(42.5%) of age . 
Kaalam Distribution 
 From the above mentioned tabulation, Among the 40 patients selected in this study, 
its shows the higher incidence was initiated to be pitha kaalam (92.5%). 
Occupational Status 
 In this study, the rate of incidence is higher in occupational group which includes 
farmers and labours (15%) House wifes (29.5%) Teachers (7.5%) and Tailors (5%). This 
study shows heavy work farmets and Labours are mostly affected. 
Seasonal variations 
 From the above mentioned tabulation 20% of patients were admitted in Muthuvenil 
kaalam, 37.5% of patients were admitted in munpanikaalam, 7.5% of patients were admitted 
in karkalam,  7.5% of patients were admitted in koothirkulam. Mostly  the patients were 
admitted in Munpani kaalam. 
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Thinai 
From the above mentioned tabulation  80% were from maratham,  20% were from 
Neithal. 
Even though siddha literatures mention maratham as a disease free zone,most of the 
patients came from maratham nilam. This may be due to the altered lifestyle, environment 
and food habits. Since this is a single centered study, located in maratham thinai it may also 
have influenced the study. 
Socio-economic status 
From the above mentioned tabulation, out of 40 patients, 57.5% were from poor 
socio-economic status. 37.5% of cases from rich background. The higher incidence in the low 
socio-economic status may be due to the over usage by farmer, and manual worker among the 
poor. The incidence in the further population group may be due to improper nutrition and also 
the people living in poor sanitation. 
Dietary habits 
From the above mentioned tabulation patients 87.5% were reported to have Non-
vegetarian, 12.5 % were reported vegetarian, so this has no statistically significant result. 
Mode of onset 
 From the above mentioned tabulation it shows that 75% of the cases were reported to 
have graduate onset. 
Duration of condition 
 Among the 40 cases, 14 cases (35%) were come under 0-3 months, 16 cases (40%) 
were come under 4-6 months, 3 cases (7.5%) were come under 7-12 months, 7 cases 
(17.55%) were come under 13-24 months. 
Clinical symptoms Inference  
       Pain, swelling of joints,  morning stiffness, tenderness, restricted movement and 
warmth were found in all the 40 patients before treatment. 
 After treatment there was a considerable reduction in all symptoms particularly in 
pain, morning stiffness, swelling of joints, tenderness, restricted movements and warmth. 
After treatment there was a complete relief in the symptoms like low grade fever, 
sleeplessness and loss of appetite. 
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Deformity 
  Among the 40 patients,22.5% cases hand spindle shaped fingers, 12.5% cases had 
ulnar deviation of hand,2.5% cases had hallus valgus , 10% cases had swan neck 
deformity,and 2.5 cases had z shaped deformity. 
Involvement of joints 
          Among the 40 cases 95% had knee joints, 95% of the cases had proximal 
interphalangeal joint,87.5% had  ankle joints, and  82.5% metacarpophalangeal joints, 62.5% 
had wrist joints, 45% had cervical spine, 40% had elbows, 25% had hip joints, 17.5 %had 
shoulder joints and 50% had meta tarsophalangeal joints 
Distribution in Kanmenthiram 
 From the above mentioned tabulation, among the patients Vaai,  Kruvai, Karuvai, Kai 
and Kaal have been affected in 100% of cases and in 8 patients eruvai have been affected 
(20%). 
Distribution of Three Dhosham 
Derangement in Vatham 
  Viyanan and Samanan were affected in all the 40 cases (100%), Udhanan were 
affected in 21 cases(52.5%), pranan were affected in 20 cases (50%) Abanan were affected in 
8 cases (20%) Kirukaran and Devathathan affected in 9 cases (22.5%) 
Derangement of Pitham 
  Sathaga pitham was affected in all 40 cases (100%) Ranjagapitham was affected in 12 
cases (30%), Anarpitham was affected in 10 cases (25%). 
Derangement in Kabam 
 Avalambagam, Santhigam was affected in all 40 cases 100%. 
Udal Kattukal 
 It was diagnosed, during the study that among the seven udalkattukal, Saaram, oon, 
Kozhuppu, Enbu ,moolai were affected in 40 cases (100%) . 
Envagai Theruvugal 
 The analysis showed the efficacy of this method and the Prime importance of Naadi. 
 Among the 40 cases Naadi have been affected in all cases while malam have affected 
in 8 cases (20%). 
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Naadi 
        As mentioned above naadi was noted in all cases and among that 20 cases (50%) were 
vathapitham, 14 cases (35%) were pithavatham, and remaining 6 cases (15%) were kabavatha 
naadi. 
Neikuri 
 In Neikuri analysis, 67.5% of the cases presented with Vatha Neer, 17.5% with 
Pithaneerx. 
 Laboratory investigations were done in all the cases before and after treatment. The 
significant variations occur in parameters like Hb, while other parameters have insignificant 
variation. 
Treatment 
 The treatment was aimed to retain the deranged dhosham and providing relief from 
symptoms. Before treatment the patient were advised to take vellai ennai - 15ml with hot 
water during early morning in empty stomach for first day of treatment. The patients was 
asked to take rest from internal Medicine and other activities on that day. From the next day 
onward the internal medicine to be given. 
 The author treated the patients with trial drugs KEEL VAYU NIVARANA 
CHOORANAM (Internal Medicine) 10-20gm BD and VATHATHIRKU THYLAM 
(External Medicine) and VEDHU (External Therapy) During treatment, the patients were 
advised to follow pathiyam (avoid tarmarind, tubers, meat etc). But all aspects of pathiyam 
could not be imposed due to practical difficulties. 
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7. SUMMARY 
          
         Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of joints with 
unknown etiology. It usually affects the peripheral joints with a symmetrical distribution. Its 
systemic manifestations include hematologic, pulmonary, and neurological and cardio 
vascular abnormalities. Its clinical course is usually life-long, with intermittent relapsing and 
remissions with highly variable severity.  
             The major goal of Therapy is to reduce pain and progression of the disease along 
with maintenance of function of the joints while maintaining capability for work and 
recreational activities. Therapy also aims at improving the quality of life and the personal 
perception of the disease burden. 
 Here I have brought out a new trial with the drug “KEELVAYU NIVARANA 
CHOORANAM” (internal) & VATHATHIRKU THYLAM” (external) in reducing not 
only the pain but also the restricted movements, and also the effect of VEDHU (steam bath) 
over the disease.  
           40 cases with Uthira vaatha suronitham were diagnosed clinically and admitted in the 
inpatient ward and outpatient ward of post graduation department of Sirappu Maruthuvam, 
Government Siddha Medical College hospital, palayamkottai and treated by the trial 
medicines. 
  In this study, first the patients were well informed about the study and they were 
asked to sign the consent form. After signing the consent form, information sheet and diatery 
advice forms were given to the patients. 
  The various Siddha methods of examination of the disease were carried out and the 
data were recorded in the prescribed Proforma for the 40 selected cases. 
  Purgation was given by administering  vellai ennai 15ml is given in early morning to 
bring the Thirithodam to equilibrium a day prior to treatment and the patient was given 
complete rest on the day of purgation. 
  The prognosis of the patients during each visit was entered and monitored for any 
adverse drug reactions or poor patient compliance, investigation reports were recorded before 
and after treatment. 
  Bio-chemical analysis revealed that the drug contains Calcium, Ferrous iron, tannic 
acid, reducing  sugar and Unsaturated compounds. 
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 From the second day onwards internal medicine. KEEL VAYU NIVARANA 
CHOORANAM 10-20gm two times day after food and VATHATHIRKU 
THYLUM and VEDHU  is given as external theraphy. 
 At the time of treatment the patients were advised to follow pathiyam and 
specially advised to avoid foods which increase vadha. 
 Daily improvement was observed to assess the efficacy. The results obtained were 
found to be propitious particularly results by combined therapies. 
 No adverse reactions were found. Hence, the trial drug was found to be safe and 
effective. 
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8. CONCLUSION 
  The result of this clinical trial indicate that trial drug is clinically effective in Uthira 
vatha Suronitham.  The toxicity study reveals that the trial drug Keel vayu nivarana 
chooranam is safe. It has analgesic and anti inflamatory activity. 
  The main aim of the treatment was to study the Therapeutic effect of the drug Keel vayu 
nivarana chooranam by its action on Pain, swelling, morning stiffness, restricted movements 
etc,.  
  In this study  all the 40 cases were treated as compained therapy 
  Hence the study concludes that, the trial drugs are clinically effective in reducing the 
pain, swelling and morning stiffness, restricted movements in Uthiravatha suronitham 
patients. However further work with large number of patients should be carried out towards 
finding the ideal dose response. 
  The treatment was aimed at normalizing the deranged thodams and providing relief 
from symptoms. 
  There were no adverse reactions complained during the trial. 
  Because of the encouraging clinical outcome, the study may be further carried out 
with the same drug in a large number of cases. 
 
.  
91 
 
 
ANNEXURE –I 
STANDARD OPERATING PROCEDURE FOR PREPARATION OF KEELVAYU 
NIVARANA CHOORANAM 
SOURCE OF TRIAL MEDICINE: 
 The required drugs for preparation of  KEELVAYU NIVARANA CHOORANAM 
(Int) and VATHATHIRKU THYLAM (Ext) and External Therapy Vedhu  will be purchased 
from a well reputed country shop and the purchased raw drugs are authenticated by medical 
botanist, Govt Siddha Medical College, Palayamkottai, then purified and the medicine is 
prepared in the Gunapadam laboratory at Govt Siddha Medical College, Palayamkottai. 
PROPERTIES OF THE TRIAL DRUG 
INTERNAL MEDICINE:  
KEELVAYU NIVARANA CHOORANAM 
INGREDIENTS : 
Sl. 
No. 
INGREDIENT BOTANICAL NAME 
PART 
USED 
MEASUREMENT 
1. Nannari ver pattai Hemidesmus indicus Bark 10thola(117gm) 
2. Parangipattai Smilax china Root 10thola(117gm) 
3. Seemai Amukkura Withania somnifera Root 10thola(117gm) 
4. Chitrarathai Alpinia galanga Root 5thola(58.5gm) 
 
Purification of drugs: 
• All the above raw drugs are purified as per the evidence mentioned in the Saraku 
suthi muraigal and Anuboga vaithiya bramma ragasiyam. 
Preparation: 
 Purified dry drug is taken and powdered. Keep in airtight container 
Dose  :  10-20 grains(650mg- 1300mg), twice a day. 
Adjuvent :  Hot Water 
Duration :  30 to 48 days  
Indications : All types of Joint lesions. 
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gwq;fpg;gl;il; ; ;; ; ;; ; ;  
 
Botanical Name       :   Smilax china 
Synonyms! ! ! ! !! !! ;! ! ! kJ];kpfk;> kJ];kPfp> rPdg;gl;il> gwq;fpr;rf;if!
Family                      :  Liliaceae 
Part used                  :  Root 
Rit           :  ,dpg;G 
tPupak;        P ;P ;P ;  :  jl;gk; 
gpupT         :  ,dpg;G 
 
Therapeutic action! ! !! ! !
 clw;Nww;wp>!
 Nkfg;gpzptpyf;fp>!
 fhkk;ngUf;fp>!
 J}a;ikahf;fp!
 
Fzk;  
“jhfk; gythfje; jhJ el;lk; Gz; gpsit 
Nkfq; fbfpue;jp tPo;%ye; NjfKld; 
Fl;il gfe;j Nkw; nfhs;tkdk; Nghk; gwq;fpg; 
gl;ilapid Ar;rupj;Jg; ghH” 
nghUs;;;; 
ePH Ntl;if> Klthjk;> FNw Neha;> ePupopT> fbtplk;> Gz; ,it ePq;Fk; 
Chemical constituents 
 7-o-seta-D-gluco pyranoside, 
 engeletin, 
 isoengeletin,  
 kaemiferol,  
 rutin, 
 vanillic acid 
 Starch 
 Gulucoside, 
 Sapponine 
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nL g<g qvig<gqp r <G< < << < << < < !
 
Botanical Name  :  Withania somnifera  
Family   :  Solanaceae 
Tamil name   :  nL g<gqiq?! gqcs<os uq?! u viggi<{ q! !
English Name  :  Winter Cherry 
Sanscrit Name  : Aswagandha 
Malayalam  :  Amukkara 
Part used   :  Rhizome 
Rit    :  ifg;G 
tPupak; P ;P ;P ;   :  ntg;gk; 
gpupT    :  fhHg;G 
 
Therapeutic Actions : 
 Sedative, 
 Tonic, 
 Deobstruent 
 Diuretic 
 Aphrodisiac 
 Soporific  
 
Chemical constituents : 
 Isopelletierine,  
 anaferine,  
 saponins, 
 sitoindosides 
 Somniferine, 
 Withanine, 
 Perinponyine, 
 
nghJFzk; :;;;  
     “nfhQ;e; JtHg;ghq; nfhbafak; #iyaup 
    kpQ;Rfug; ghd;ghz;L ntl;gjl;G - tpQ;rp 
KfTW NjhlKk;Ngh Nkhfk; mdYz;lhk; 
 mRtfe; jpf;nfd; wwp” 
- mfj;jpaH Fzthflk;!
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sqx <x vk <j k< << << <  
Botanical Name  :  Alpinia Officinarum 
Family   :  Zingiberaceae 
Tamil name   :  Chittaratai 
English Name  :  Lesser Galangal 
Sanscrit Name  : Rasna  
Malaiyalam  :  Aratha 
Part used   :  Rhizome 
Rit    :  fhHg;G  
tPupak; P ;P ;P ;   :  ntg;gk; 
gpupT    :  fhHg;G 
 
Therapeutic Action : 
 
 Expectorant  
 Febrifuge  
 Stomachic  
 Carminative  
 
Chemical constituent : 
 
 Galangol 
 Galangin 
 Volatile oil 
 Diaryheptanoid  
 Sterol 
 Flavinoids  
ohi KG{ l<< <<: !
! uik hqk <! k r<gVh<hie<! u ik R<! sqOviOvigR< !
! Osi<f<k gh! L k <Ok imR<! sQ k ol iM !–! Ofi<f<k ! Svl <!
! l x <x vk<j k g<! gim<c! uV l qVl ! Z f<k QVl <!
! sqx <x vk <j k ! ue<l Vf<k iz<! Ok i</!
. Ok ve<! G{ uigml < !
 utq?! J bg<Gx <x r <gt<?! gvh<hie<?! ui B?! k j z O fib<?! sQk tl <?! - Vl z<?! hz ! Svl <!
N gqbj u! Ohil </!
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f e<e iiq< << !
Botanical Name  :  Hemidesmus Indicus 
Family Name  :  Asclepiadaceae  
Tamil Name   :  Ankaaramooli, Narunetti, Neerundi, Paathalamuli, 
Ayurvedic Name  :  Sveta Sariva, Anantmool  
Unani Name   :  Ushba 
Hindi Name   :  Anantamul 
Part Used   :  Root  
Rit           :   ,dpg;G, ! sqX j gh<H !
tPupak;        P ;P ;P ;  :   jl;gk; 
gpupT          :   ,dpg;G 
Therapeutic Action 
 Demulcent,  
 Alterative, 
 Astringent, 
 Diaphoretic, 
 Diuretic, 
 Tonic, 
 Anti-pyretic,  
 Blood purifier. 
Chemical consitutent : 
Root contain : 
  Hexatriacontane, 
  Lupeol, Its Octacosanoate, 
  α-Amyrin, β-Amyrin, Its Acetate And Sitosterol.  
 Coumarino-Lignoid-Hemidesminine, 
 Hemidesmin I and Hemidesmin Ii50,  
 Six Pentacyclic 
  Triterpenes Including two Oleanenes, and three Ursenes 
 The Stem Contains  
 Calogenin Acetylcalogenin-3-0-β-D-Digitoxopyrannosyl-0-β-D-
Digitoxopyronsyl-0-β-D-Digitoxopyranoside.  
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 3-Keto-Lup-12-En-21 28-Olide along with Lupanone, 
 Lupeol-3-β-Acetate, 
 Hexadecanoic Acid 
 , 4-Methoxy-3-Methoxybenzalaldehyde and 3-Methoxy-4-
5methoxybenzalaldehydglycosides-Indicine and Hemidine. 
The leaves contain  
  Tannins, 
  Flavonoids,  
 Hyperoside, 
  Rutin and Coumarino 
 .Leucoderma Lignoids such as Hemidesminine,  
 Hemidesmin I and Hemidesmin Ii are rare Group of naturally occurring 
compounds presentiIn Leaves. 
 
Therapeutic Uses 
 The root of the Hemidesmus plant is demulcent, alterative, astringent, diaphoretic, 
diuretic, tonic, anti-pyretic, and blood purifier. 
 It is used in leprosy, skin diseases, fever, asthma, bronchitis, syphilis, pruritus and 
other urinary diseases, chronic rheumatism, and leucorrhoea. 
 
ohi KG{ l<< << !
“sz Ok iml <! hqk <k l k q! k igl <! dp j z!
sz Ol X ! sQk l qe<eiI! k R<$.M z gl k qx<!
osie<el K! Ol gl <! H{ < ! Svl qj uob! z iol ip qg<Gl <!
ol e<l Kv! fe<ei iq! Oui < !
. Ok ve<! G{ uigml < !
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EXTERNAL MEDICINE:  
VATHATHIRKU THYLAM 
INGREDIENTS BOTANICAL NAME PART USED MEASUREMENT 
1.Manipungu Sapindus laurifolia Outer layer 35gm 
2.Erukku verpattai Calotropis gigantea Root bark 35gm 
3.Murukkilai charu Erythrina variegata Leaf 250ml 
4.Velai charu Cleome viscosa Leaf 250ml 
5.Goat’s milk   1/3 amount of above 
extract (83 Ml) 
6.Castor oil Ricinus communis  ½ amount of above 
extract (125 Ml) 
 
Method of preparation: 
 Grind the ingredients 1 and 2,make it into kudineer and then add the remaining 
ingredients with it and boil until required consistency formed. Filter it then kept in a dry 
airtight container.  
 
Vedhu (Thazhuthazhai) is manipulated in patients depending upon the severity of 
illness 
 Ref: Aruvaimaruthvam (page.no:40-41) 
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Erukku 
Tamil Name  : Erukku  
NtWngah;;;;  : mUf;fd; 
English Name  :  Madar 
Botanical Name :  Calatropis Gigantea 
Family    :  Asclepiadaceae 
Part Used  :  Root 
Rit     : ifg;G fhuk; ,dpg;G 
jd;ik      : ntg;gk; 
gphpT       : fhh;g;G 
Constituents: 
 Beta amyrin,  
 alpha isomeric crystalline alcohols,  
 giganteol,   
 iso iganteol. 
Action  
 Alterative 
 Tonic 
 Antispasmodi 
 
nghJFzk; :;;;  
 kd;didAq; ifnaLf;f itj;njapw;wp Ndafw;wp 
 Ad;D gpzpg;gzpia Nahl;Ljyhw; -nrhd;Ndd; 
 vUf;nfdNt G+kp apdpNy tpsq;Fk; 
 mUf;f kUf;fndd yhk;      
(Nj.ntz;gh) 
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ey;Ntis;;; !!
!
English Name ! ;! Dog mustard!
Parts used ! ;! ,iy> G+> tpij> Nth; 
Rit   : fhHg;G> 
jd;ik  : ntg;gk;> 
gphpT    : fhHg;G 
 
Action 
GOf;nfhy;yp ! . Anthelmintic!
,rptfw;wp! ! .! Antispasmodic!
mfl;Ltha;tfw;wp ! .! Carminative!
tpah;itngUf;fp .! Diaphoretic!
jbg;Gz;lhf;fp ! .! Rubefacient 
 
Chemical Constituents: 
 Essential oil 
 Tarpenes  
 Flavonoids 
 Anthocyanins 
 Alkaloids  
 
nghJFzk; :;;;  
“rpuNeha; typFilr;ry; jPuhr; rapj;jpak; 
cuNeh apitf nshopAk; - cuNkTk; 
tpy;Ntisf; fhAk; tpopaha; grpnfhLf;Fk; 
ey;Ntis jd;id etpy;.” 
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Manipungu 
Botanical Name  : Sapindus Laurifolia 
Family  Name :   Sapindacea 
Tamil Name   :  Ponnankaai,Punkumaram, Poovunthi 
English Name  : Soap Nut, 
Sanscrit Name  : Arishta,  Aristaphalam 
Hindi Name   :  Ritha 
Part used   :  -j z ?! gib< 
Sj u! ! ! ;! j gh<H?! Kui<h<H !
k e<j l< << ! ! ;! ouh<hl < !
hqi qU ! ! ! ;! giIh<H !
Therapeutic action : 
 Expextorent  
 Nauseact 
 Anthelmintic  
Chemical constituents : 
 Saponins 
 Giygeride  
 Flavonoids  
 Quercetin  
 Apigenin  
 Rutin  
 Triterpene   
 Triglycerids  
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Murukkilai 
Botanical Name :  Erythrina variegate 
Family  Name  :   Fabaceae  
Tamil Name   :  L t<! L Vg<G?! gqR<Sgl < 
English Name  :  Indian Coral Tree, 
Sanscrit Name  :  Parijataka, Kimsukam, Mandaya 
Hindi Name   :  Ferrad ,Mandar 
Part used   :   -j z ?! H,?! uqj k ?! hm<jm !
Sj u! ! ! ;! j gh<H?! giIh<H !
k e<j l< << ! ! ;! ouh<hl < !
hqi qU ! ! ! ;! giIh<H !
 
Therapeutic action : 
 Expextorent  
 Anthelmintic  
 Febrifuge  
 Anti –bilious 
 
Chemical constituents: 
 Alkaloids 
 Flavoniods  
 Pterocarpans  
 Triterpenes  
 Steroids  
 Alkyl transferulates  
 Lecithin  
 proteins 
ohi KG{ l<< << !
L t<T! L Vg<gKk ie<! O l iKgqe<x ! si<k <k qGe<l l r <!
gt<tl x k<! k QIg<Gr <! gex <SvL l <! uqt<tiqb!
ng<gvL l <! Ohig<G! l ez<uib<Oug <! gimgx <X l <!
l qg<gu! uzqogiM g<Gl <! uqt</ !
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Mkzf;F ;;; vz;nza; (tpsf;nfz;nza;); ; ; ; ;; ; ; ; ;; ; ; ; ;  
 
Botanical Name  : Ricinus Communis 
Family   : Euphorbiaceae. 
NtW ngaH   : Vuz;lk;> rpj;jpuk;> jy&gk; 
Part Used   : Seed 
Rit   : frg;G 
tPhpak;P ;P ;P ;   : ntg;gk;;;; 
gphpT   : fhHg;G 
Therapeutic Actions  :   
 Laxative, 
 Emollient 
Chemical Constituents :   
 Ricinine, 
  Ricin, 
  Resin 
nghJFzk;: ;;;  
Mkzf; nfz;nza; jd;id azpepy kwpa Nfz;kpd; 
G+kzr; re;JNjhWk; nghUe;jpa thjk; Nghf;Fk; 
jPke;jj; jhDk; Nghf;Fe; jpfo;Tld; tpiuT Kz;lhk; 
jPkdf; Flypy; thjQ; NrHFl Nyw;wk; NghNk 
- vL 
nghUs; :;;;  Mkzf;nfz;nzapdhy; thjk; ePq;Fk;. 
nts;shl;Lg;ghw; Fzk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
“out<tim<M ! hiZ g<GOl uqbfx <! x Qhel if< !
! k t<tiM ! uik hqk<k R<! sif<k l il <! .! dt<tqj vh<Hs< !
! sQk l k q! sivR<! sqOz ]<l l X l<! H{ <{ iX l<!
! uik ! sqOz ]<l L h<Ohi! l ib<f<K”/ !
nghUs;;;; 
 nts;shl;Lg; ghypdhy; thjgpj;j njhe;jk;> Rthr fhrk;> rPjhjprhuk;> fgNjh\k;> 
tpuzk;> thjj;jpYz;lhfpa tPf;fk; Kjypa Jd;ge;jPUk;.  ey;ygrpAk; cz;lhnkd;f. 
Drug storage: 
 The trial drug KEELVAYU  NIVARANA CHOORANAM (internal) is stored in 
clean and dry airtight container and  VATHATHIRKU THYLAM (external) is stored in 
clean and dry pet bottles. 
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INTERNAL MEDICINE-KEEL VAYU NIVARANA CHOORANAM 
 
 
   NANNARI VER PATTAI                                                       PARANGI PATTAI 
                                           
          
       CHITHARATHAI                                                            SEEMAI AMUKKURA 
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EXTERNAL MEDICINE-VATHATHIRKU THYLAM 
VELAI CHARU 
 
MURUKKILAI CHARU 
 
ERUKKU  
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MANIPUNGU 
 
GOAT MILK 
 
CASTOR OIL 
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KEEL VAYU NIVARANA CHOORANAM 
 
 
VATHATHIRKU THYLAM 
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ANNEXURES -II 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
BIO-CHEMICAL ANALYSIS OF KEEL VAYU NIVARANA CHOORANAM 
(IN POWDER FORM) 
 
PREPARATION OF THE EXTRACT:  
5 grams of the drug was weighed accurately and placed in a 250ml clean beaker. Then 
50ml of distilled water added to it and dissolved well. Then it was boiled well for about 10 
minutes. It was cooled and filtered in a 100ml volumetric flask and then it is made upto 
100ml with distilled water. This fluid was taken for analysis. 
 
QUALITATIVE ANALYSIS 
S. 
No. 
EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube. To this add 
2ml of 4% Ammonium oxalate solution. 
A white precipitate is 
formed 
Absence of calcium. 
2 
TEST FOR SULPHATE 
2ml of the extract is added to 5% 
Barium Chloride solution 
A white precipitate is 
formed 
Indicates the 
presence of sulphate 
3 
TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution. 
A white precipitate is 
formed 
Absence of chloride. 
4 
TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
No brisk efference is 
formed 
Absence of 
Carbonate 
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5 
TEST FOR STARCH 
The extract is added with weak iodine 
solution 
Blue Colour is 
formed. 
Indicates the 
presence of Starch 
6 
TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro cyanide. 
No blue color is 
formed. 
Absence of ferric iron 
7 
TEST FOR FERROUS IRON 
The extract is treated with concentrated 
Nitric acid and Ammonium thiocyanate 
solution. 
Blood red colour is 
formed. 
Indicates the 
presence of ferrous 
Iron. 
8 
TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow precipitate 
is formed 
Absence of 
Phosphate 
9 
TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No yellow precipitate 
is formed. 
Absence of Albumin. 
10 
TEST FOR TANNIC ACID 
This extract is treated with ferric 
chloride. 
No blue back 
precipitate is formed 
. Absence of tannic 
acid 
11 
TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract. 
It gets decolorized 
Indicates the 
presence of 
unsaturated 
compound 
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12 
TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil 
for 2 minutes and add 8-10 drops of the 
extract and again boil it for 2 minutes 
Colour change occurs 
Indicates the 
presence of reducing 
sugar 
13 
TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried well. 
After drying 1% Ninydrin is sprayed 
over the same and dried it well. 
violet colour is 
formed. 
Indicates the 
presence of Amino 
Acid. 
14 
TEST FOR ZINC 
The extract is treated with Potassium 
Ferro cyanide. 
No white precipitate 
is formed. 
Absence of Zinc. 
  
RESULTS AND DISCUSSION: 
 The Bio chemical analysis of the trial drug Keelvayu Nivarana Chooranam was 
tabulated above in table 2. 
 The trial drug Keelvayu Nivarana chooranam contains. 
1. Sulphate 
2. Ferrous Iron 
3. Unsaturated compound 
4. Reducing sugar 
5. Amino Acid. 
6. Starch 
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ANNEXURE  III 
FTIR ANALYSIS OF SIDDHA  MEDICINE KEEL VAYU NIVARANA 
CHOORANAM 
FTIR characterization shows the presence of some functionalgroup such as Halo 
compound, Phenol, Nitro compound, Amine where identified in Siddha poly herbal 
formulation.  “keel vayu nivarana chooranam”.  
Keywords : FTIR,Siddha,keel vayu nivarana chooranam . 
 FTIR characterization was done for the poly herbo and mineral Siddha formulation 
“SarvangavathaChooranam” to identifythe functional group.  Each molecule or chemical 
structure will produce a unique spectral fingerprint, making FTIR analysis a great tool for 
chemical identification.Bio chemical analysis was done to evaluate the acid and basic radicals 
present in the formulation.  
 
INGREDIENTS : 
Sl.  
No. 
INGREDIENT BOTANICAL NAME 
PART 
USED 
MEASUREMENT 
1. Nannari ver pattai Hemidesmus indicus Bark 10thola(117gm) 
2. Parangipattai Smilax china Root 10thola(117gm) 
3. Seemai Amukkura Withania somnifera Root 10thola(117gm) 
4. Chitrarathai Alpinia galanga Root 5thola(58.5gm) 
 
FTIR Spectrum analysis 
 Fourier transform infrared spectroscopy is an important and more advanced 
technique.  It is used to identify the functional group to determine the quality and consistency 
of the sample material and can determine the amount of compound present in the sample. 
 In FTIR- infrared is passed from a source through a sample.  This infrared is absorbed 
by the sample according to the chemical properties and some are transmitted.  The spectrum 
that appears denotes the molecular absorption and transmission.  It forms the molecular finger 
print of the sample.  It is recorded as wavelength and the peaks seen in the spectrum indicate 
the amount of material present. 
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Fig.1. Image of the FTIR spectrum. 
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Table.2: FTIR Data interpretation of KEEL VAYU NIVARANA CHOORANAM 
Wave number Vibrational modes of KVNC In IR region Functional groups 
520.278 C-1 Strech Halo compound 
574.79 C-I Strech Halo compound 
765.74 C-cl strech Halo compound 
1157.29 C-oStrech Fluoro compound 
1367.53 S=OStretch Sulfonate 
1367.53 O-H Bending Carboxylic acid 
1512.19 N-O Strech Nitro compound 
1512.19 N-H Bending Amine 
2357.01 O=C-O Stretch Carbondioxide 
2827.64 C-H Stretch Alkane 
2782.58 C-HStrech Alkane 
2943.37 N-HStrech Amine salt 
 
       In FT-RI SPECTRA ANALYSIS ,This sample keel vayu nivarana chooranam exhibit the 
peak value at 2782.58520.278, 574.79, 765.74, 1157.29, 1367.53, 1367.53, 1512.19, 1512.19, 
2357.01, 2827.64,  2943.37.having  C-1 Strech, C-cl stretch, C-oStrech, S=OStretch, O-H 
Bending, N-O Strech, N-H Bending, O=C-O Stretch, C-H Stretch, N-HStrech. 
 
FTIR RESULTS AND DISCUSSIONS 
         This indicates the presence of some organic functional groups such asHalo 
Compound,Fluoro compound, Aromatic Ester, Phenol, Nitro compound, Amine, Alkane 
respectively. 
 The presence of Amine commonly used as analgesics in medicine that relieves pain.   
The presence of aromatics are good pain relievers has anti-pyretic, anti-inflammatory, auto-
immune activities.The presence of Halo compounds are  used for treatment of typhoid 
fever.The presence of phenol is an active ingredient in some oral analgesics, likewise the 
presence of other these identified functional groups in the medicinal compound are also 
responsible for the therapeutic function of drug “keel vayu nivarana chooranam” 
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ANNEXURE – IV 
PHARMACOLOGICAL ANALYSIS 
ANALGESIC ACTIVITY 
 Analgesic activity of Keel Vayu Nivarana Chooranam at a dose of 100 mg/kg and 
200mg/kg was evaluated by acetic acid induced writhing reflux in mice.  Painful reaction in 
animals may be produced by the chemicals such as phenylquinone, bradykinin etc.  Like that, 
acetic acid pain reaction which is characterized as a writhing response.  Construction of 
abdomen, turning of trunk (twist) and extension of hind legs are taken as reaction to 
chemically induced pain.  Analgesics (both narcotic and non-narcotic) inhibit writhing 
response. 
REQUIREMENTS 
Animal  : Swiss albino mice (20-25g) either sex 
Drugs and chemicals : Diclofenac sodium (standard),  Acetic acid (1%v/v), Keel Vayu  
Nivarana Chooranam. 
METHOD 
TREATEMENT PROTOCOL 
Group 1:  Treated as normal control received 10ml/kg of normal saline through orally. 
Group 2:  Treated as standared control received 10mg/kg of diclofenac sodium through  
Intraperitoneally. 
Group 3:  Treated as treatement control received 100mg/kg of Keel vayu nivarana 
chooranam with 2ml of sterile water administered  through orally. 
Group 4:  Treated as treatement control received 200mg/kg of Keel vayu nivarana 
chooranam with 2ml of sterile water administered  through orally. 
 Both dose of Keel vayu nivarana chooranam were administered one hour prior to the 
acetic acid administration.  Note the onset on writhing.  Record the numbers of abdominal 
contractions, trunk twist and extension of hind limbs as well as number of animals showing 
such response during a period of 10 minutes were noted. 
STATISTICS 
 Data are expressed as mean ± SEM; data analyzed by one way ANOVA followed by 
Newman’s keul’s multiple range tests to determine the significance of the difference between 
the control group and rats treated with the extracts. 
• Values were considered significant at P< 0.01. 
114 
 
 
TABLE NO.3 
ANALGESIC  ACTIVITY  OF KEEL VAYU NIVARANA CHOORANAM IN 
AGAINST ACETIC ACID INDUCED WRITHING REFLUX IN MICE 
Treatment Dose (mg/kg) No.of 
writhing 
% reduction in 
reaction time 
Group I 
Normal saline 
Inject 1%v/v 
acetic acid 
1ml/100g of body 
weight 
38.0±3.5 - 
Group II  
Std 
10mg/kg I.P.Diclofenac 
sodium 
5.50±0.8 85.52%** 
Group III 
Keel vayu Nivarana 
Chooranam 
100mg/kg 
Administered through 
orally 
11.05±3.0 70.92%** 
Group IV 
Keel vayu Nivarana 
Chooranam 
200mg/kg 
Administered through 
orally 
9.8±2.0 74.21%** 
 
Values are expressed as mean ±SEM 
Values were find out by using one-way ANOVA followed by Newman’s keuls multiple 
range tests. 
** Values were considered significant at P<0.001. 
RESULTS 
 The table values show that analgesic activity of Keel vayu nivarana Chooranam at a 
dose of 100 mg/kg and 200mg/kg by aceticacid induced writhing reflex.  The results reveals 
that both doses of Keel vayu nivarana chooranam  possess significant analgesic activity at 
P<0.001. 
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ANTI-INFLAMMATORY ACTIVITY OF KEEL VAYU NIVARANA CHOORANAM 
AGAINST CARRAGEENAN INDUCED PAW EDEMA IN RATS 
 The anti-inflammatory activities of Keel vayu nivarana chooranam at a dose of 
100mg/kg and 200mg/kg body weight were evaluated using carrageenan induced paw edema 
method.  The inflammation was readily produced in the form of edema with the help of 
irritant such as carrageenan.  Carrageenan is a sulphated polysaccharide obtained from sea 
weed (Rhodophyceae) and when injected cause the release of prostaglandins by the way it 
produces inflammation and edema. 
 
REQUIREMENTS 
Animal  : Albino rat (180-200g) 
Drugs and chemicals : Carrageenan (1%w/v), Diclofenac sodium (standard),  
Keel vayu nivarana chooranam. 
Digital plethysmo meter. U G O Basile (Italy) 
 
METHOD 
The animals were divided into 4 groups each having six animals. 
The animals were divided into 4 groups each having six animals. 
 
TREATMENT PROTOCOL 
Group1 : Treated as normal control received 10ml/kg of normal saline through orally. 
Group 2 : Treated as Standared control received 10mg/kg of diclofenac sodium through  
intraperitoneally. 
Group 3:  Treated as treatment control received 100mg/kg of Keel vayu  
nivarana chooranam  
dissolved with 2ml sterile water and administered through orally. 
Group 4:  Treated as treatement control received 200mg/kg of Keel vayu nivarana  
chooranam dissolved with 2ml sterile water and administered through orally. 
 A freshly prepared suspension of carrageenan (1% w/v, 0.1ml) was injected to the 
planter region of left hind paw of each rat.  One group was kept as control and the animals of 
the other groups were pretreated with the Keel vayu nivarana chooranam given through orally 
60 min before the carrageenan treatment.  The paw volumes of the tst compounds, standard 
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and control groups were measured at 60,240, 360 minutes of carrageenan treatment with the 
help of Digital  plethysmometer (Ugo basile, Italy).  Mean increase in paw volume was 
measured and the percentage of inhibition was calculated. 
% Anti-inflammatory activity = (Vc-Vt/Vc) x 100 
 Where Vt-mean increase in paw volume in rats treated with test compounds.  Vc-
mean increase in paw volume in control groups of rats. 
 
STATISTICS 
 Data are expressed as mean ± SEM, data analyzed by one way ANOVA followed by 
Newman’s keul’s multiple range tests to determine the significance of the difference between 
the control group and rats treated with the test compounds. 
• Values were considered significant at P<0.01. 
 
TABLE NO.1 
ANTIINFLAMATORY ACTIVITY  OF KEEL VAYU NIVARANA CHOORANAM 
 
Treatment Dose (mg/kg) 
Paw volume (ml) as 
measured by 
mercury 
displacement at 6 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 
10ml/kg orally 5.70±0.98 - 
Group II  
Std 
10mg/kg I.P.Diclofenac 
sodium 
1.62±0.40 71.57%*a 
Group III 
 
100mg/kg 
Administered through orally 
2.0±0.58 64.91%*a 
Group IV 
 
200mg/kg 
Administered through orally 
1.74±0.72 69.47%*a 
*Data are expressed as Mean ± S.E.M. 
*Data were analyzed by one way ANOVA followed by Newman’s keul’s multiple range 
tests, to determine the significance of the difference between the control groups and rats 
treated with the test compounds. 
*a Values were significantly different from normal control at P<0.01. 
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RESULTS 
ANTI-INFLAMMATORY ACTIVITY 
 Keel vayu nivarana chooranam at a dose of 100 and 200mg/kg were tested for their 
Anti-inflammatory activity by using carrageenan induced rat paw edema method and the 
results are tabulated in table no.1.  The results reveals that both doses of Keel vayu nivarana 
chooranam 100 and 200 mg/kg possesses significant Anti-inflammatory activity when 
compared to control group at p<0.01. 
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ANNEXURE - V 
ACUTE TOXICITY STUDY 
 Acute oral toxicity refers to those adverse effects occurring following oral 
administration of a single dose of a substance or multiple doses given within 24 hrs.  Acute 
toxic class method (OECD guidelines, (2000) was followed to arrive at the maximam safety 
dose of the drug extracts.  Three wistar strain female albino rats (8-12 weeks old, 180-200g 
body weight) were used in each group.  Single dose (2g/Kg) of the keel vayu nivarana 
chooranam food sample was orally administered to overnight fasted (food but not water 
withheld) animals while control animals received the vehicle (0.3%w/v CMC).  Animals 
were observed individually after dosing at least once during the first 30 minites, periodically 
during the first 24h, with special attention given during the first 4 hrs and daily thereafter, for 
a total of 14 days.  Body weights of the animals were recorded.  The other observations 
include changes in skin, fur, eyes and mucous membranes, respiratory, circulatory and 
autonomic and central nervous system and somatomotor activity and behavior pattern.  At the 
end of 14 days, all animals were subjected to gross necropsy. 
STATISTICAL ANALYSIS 
 Results were expressed as Mean±Standard  Error Mean (S.E.M).  Statistical 
significance was determined by one-way analysis of variance (ANOVA) followed by 
newmann keul’s multiple range tests.  P values less than 0.05 were considered significant. 
Results 
Acute toxicitystudy 
 All of the rats fed with the keel vayu nivarana chooranam showed normal general 
behavior, respiratory pattern, cardiovascular signs, motor activities reflexes and normal 
change in skin and fur. 
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TABLE NO.1 
HEMATOLOGICAL VALUES OF KEEL VAYU NIVARANA CHOORANAM IN 
THE ACUTE TOXICITY STUDY 
S.NO. PARAMETER CONTROL 
SAMPLE 
2g/kg 
1. White blood cells (X103/µl) 8.15±0.65 7.92±0.35 
2. Hemoglobin (g/dl) 12.75±0.55 11.64±0.36 
3. Mean corpuscular volume 69.50±1.15 69.05±0.90 
4. Mean corpuscular hemoglobin 
cone.(g/dl) 
36.75±0.60 35.25±0.45 
5. Platelet (X105/µl) 5.50±0.60 5465±0.55 
6. Red blood cell (X106/µl) 3.72±0.40 3.65±0.50 
 
• Values are expresses as mean ± S.E.M. 
• All groups were treated with oral dose of 2g/kg body weight 
• No significant different from normal control. 
 
TABLE NO.2 
BLOOD CHEMICAL  VALUES OF KEEL VAYU NIVARANA CHOORANAM IN 
THE ACUTE TOXICITY STUDY 
S.NO. PARAMETER CONTROL 
SAMPLE 
2g/kg 
1. Glucose (mg/dl) 112.55±4.85 148.40±4.65 
2. Bun (mg/dl) 35.70±1.62 37.60±1.70 
3. creatinine (mg/dl) 0.46±0.08 0.5±0.18 
4. Total protein (g/dl) 5.30±0.22 5.45±0.35 
5. Albumin (g/dl) 4.15±0.25 4.40±0.40 
6. Total bilirubin (mg/dl) 0.40±0.15 0.48±0.24 
7. AST(u/i) 138.58±4.30 141.05±4.45 
8. ALT(u/i) 87.35±2.35 87.30±2.50 
9. ALP(u/i) 74.40±2.60 75.50±2.75 
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• Values are expresses as mean±S.E.M 
• All groups were treated with oral dose of 2g/kg body weight 
• No significant different from normal control. 
 
DISCUSSION AND CONCLUSION 
 In acute toxicity study for 14 days, at a dose of 2g/kg of Keel vayu nivarana 
chooranam sample were chosen for the experiment.  In the aspect of general behavior the rats 
treated with food sample at a single dose had no signs of behavior changes and toxic signs.  
The treated groups revealed no significant differences in body weight gain.  The increase of 
body weight may have resulted from physiological changes in rats such as metabolism, food 
and water intake.  However, the result from animal health monitoring in the entire period of 
14 days showed no sign of morbidity and diseases. 
 The albino wistar rats were healthy as shown by the normal appearance of general 
behavior, respiratory pattern, cardiovascular signs, motor activities, reflexes and normal 
change in skin and fur. 
 In regard to hematological values, most of values in treated groups were normal in 
comparison with the control group.  Significantly, some values were different from those of 
the control group such as RBC, MCV, MCHC, and platelet.  However, such values are within 
the normal ranges.  These variations may have resulted from normal variation among animal 
groups (Feldman et al., 2000) (Inala et al, 2002).  Therefore, these results suggest that the 
keel vayu nivarana chooranam did not cause hematological or immunological defects in rats. 
 Furthermore, blood chemical examination was performed in order evaluate any toxic 
effects on liver.  In this study, the levels of these blood chemical values were minor changes 
and remained within the normal range (Caisey and King, 1980) (Levine, 1995) 
(Angkhasirisapet.al.,2002).. 
 In conclusion, Keel vayu nivarana chooranam sample given orally to wistar rats did 
not produce toxicities. 
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ANNEXURE –VI 
ASSESSMENT FORMS 
 
FORM I  :  Screening form 
FORM II  :  Consent form 
FORM III  :  History Proforma 
FORM IV  :  Clinical Assessment  
FORM V   :  Laboratory investigation 
FORM VI  :  Drug Compliance Form  
FORM VII  :  Adverse Reaction form 
FORM VIII  :  Patient withdrawal form 
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GOVERNMENT SIDDHA MEDICALCOLLEGE& HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU NIVARANA CHOORANAM 
[INTERNAL],VATHATHIRKU THYLAM  [EXTERNAL]AND VEDHU [EXTERNAL 
THERAPY] FOR THE TREATMENT OF UTHIRA VAATHA 
SURONITHAM[RHEUMATOIDARTHRITIS]. 
     FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1.OPD/IPD No: ___________     2.Date: _____3.SI.No: ________4.Name:  _________ 
5. Age:       6.Gender:         7. Phone No:. 
INCLUSION CRITERIA: 
• Age : 18-60 years 
• Sex : both male and female 
• Symmetrical joint involvement 
• Arthritis of 3 or more joints 
• Rheumatoid factor positive 
• Morning stiffness 
• Swelling especially in the inter phalangeal joint. 
• Patients who are willing for admission and stay in IPD for 30 to 48 days or willing to 
attend OPD 
• Patient who is willing to undergo radiological investigation and give blood and urine 
samples for laboratory investigation. 
• Patient willing to sign the informed consent stating that he/she will consciously stick 
to the treatment during 30 to 48 days but can OPD out of the trial of his/her own 
conscious discretion. 
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EXCLUSION CRITERIA: 
• Systemic illness. 
• Pregnant Women and Lactating Mother  
• History of trauma 
• Neurological disorder 
• Tubercular arthritis 
• Any other serious illness 
• Psoriatic arthritis 
• Gouty arthritis  
WITHDRAWAL CRITERIA: 
• Intolerance to the drug and development of adverse reactions during drug trial 
• Poor patient’s compliance and defaulters. 
• Patient turned unwilling to continue in the course of clinical trial. 
• Occurrence of any serious illness. 
 
DATE  : 
STATION :      Signature of the Investigator 
 
 
 
 
 
        Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF  SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU NIVARANA 
CHOORANAM[INTERNAL],VATHATHIRKU THYLAM [EXTERNAL]AND VEDHU 
[EXTERNAL THERAPY] FOR THE TREATMENT OF UTHIRA VAATHA 
SURONITHAM[RHEUMATOPID ARTHRITIS]. 
FORM-II 
CONSENT FORM 
Certificate by Investigator 
 I certify that I have disclosed all details about the study in the terms readily understood by 
the patient. 
Date: ……………..         Signature of the 
Signature of the Investigator: ……………..      Guide/HOD: ……………………. 
Name: ……………………………..       Name: …………………………… 
Consent by Patient 
  I have been informed to my satisfaction, by the attending physician, the purpose of the clinical trial, 
and the nature of drug treatment and follow-up including the laboratory investigations to be 
performed to monitor and safeguard my body functions. 
    I am aware of my right to withdraw from the trial at any time during the course of the trial 
without having to give the reasons for doing so. 
    I, exercising my free power of choice, hereby give my consent to be included as a 
clinical trial of KEEL VAYU NIVARANA  CHOORANAM 
[INTERNAL],VATHATHIRKU THYLAM [EXTERNAL]AND VEDHU [EXTERNAL 
THERAPY] IN UTHIRA VAATHA SURONITHAM[RHEUMATOID ARTHRITIS]. 
Date: ………………..   Signature: ………………………………… 
Name: …………………………………….  
  Date: ………………..    Signature of Witness: ……………………. 
Name………….. ………………………… 
Relationship: ………………………….. 
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murpdH rpj;jkUj;Jtf; fy;Yhhp kw;Wk; kUj;Jtkid; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
ghisaq;Nfhl;il; ;; ;; ;  
gl;l Nkw;gbg;G rpwg;G kUj;Jtj;Jiw; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 
‘fPy; thA epthuz P ;P ;P ; #uzk;” kw;Wk; ‘thjj;jpw;F ijyk; ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; - NtJ” ,tw;wpd; ghpfhpg;Gj; ; ; ; ;; ; ; ;; ; ; ;
jpwidf; fz;lwpAk; kUj;JtMa;Txg;Gjy; gbtk; Ma;thsuhy; rhd;wspf;fg;gl;lJ.; ; ; ; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ; ; ; ;  
 
ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GhpAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp  :     Jiwj;jiytu; ifnahg;gk;:  
,lk; :      ngaH: 
Ma;thsh;ifnahg;gk;:   
ngau;: 
 
Nehahspapd; xg;Gjy;; ; ;; ; ;; ; ; 
 vd;dplk; ,e;jkUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ikkw;Wk; 
kUj;Jt topKiwiag; gw;wpAk; njhlHe;J vdJ cly; 
,af;fj;ijfz;fhzpf;fTk;>mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
ghpNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; 
$wg;gl;lJ. 
 ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; chpikia 
njhpe;jpUf;fpd;Nwd;. 
 ehd; vd;Dila Rje;jpukhfj; NjHT nra;Ak; chpikiaf; nfhz;L cjpu thj 
RNuhzpjk;  vd;Dk; Neha;f;fhd fPy; thA epthuz #uzk;” kw;Wk; ‘thjj;jpw;F 
ijyk; - NtJ Mfpatw;wpd; ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F 
vd;id cl;gLj;jpf;nfhs;s xg;Gjy; mspf;fpNwd;. 
Njjp :       ifnahg;gk;: 
,lk; :       ngaH :  
       rhl;rpf;fhuHifnahg;gk;: 
       ngaH:  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU  NIVARANA CHOORANAM 
[INTERNAL], VATHATHIRKU THYLAM [EXTERNAL]AND VEDHU [EXTERNAL 
THERAPY] FOR THE TREATMENT OF UTHIRA VAATHA SURONITHAM 
[RHEUMATOID ARTHRITIS]. 
FORM III 
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _______________                 2. OPD/IPD No:_________ 
 
 
3.Name: ____________                                                          4. Gender:  
 
 
5. Age (years): _________   DOB    
      Date       Month            Year 
 
6.Address: -------------------------------------- 
 -------------------------------------- 
 -------------------------------------- 
 
7.A. Occupation:    -----------------------------                         B. Income ----------------- 
 
 
8. Educational Status:   A) Illiterate                  B)Literate  
 
 
9. Height: ----------cms                10.Weight:----------kg 
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11. Complaints and Duration: 
12. Past History                     
 Hypertension    ______________      
 Diabetes mellitus ______________      
 Asthma  ______________      
 PT   ______________ 
Other   ______________ 
 
13. HABITS 
 
A) Smoking  : 1. Yes                 duration ________ years;    Number- _____     2.No  
 
B) Alcoholism:1. Yes  duration ________ years;    Quantity- ____ ml 2.No  
 
C) Tobacco chewing:  1. Yes                duration ________ years                         2.No 
 
D) Betel chewing     :  1. Yes                duration ________ years                 2.No 
 
14. Dietary style:   A.Pure vegetarian              B.Non-vegetarian                C. Mixed diet 
 
15. Drug history:Had the patient been treated before with allopathy drug?  
 
A) Yes              2) No                                     
 
16 Marital status:1.Married         2.Unmarried                                                  
 
17. Family history : 
 
      Whether this problem runs in family?             1. Yes                               2.No   
 
(If yes, mention the relationship)  
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18. Bowel habits & micturition:      Normal                     Abnormal 
 
(Details of an abnormality) 
 
 
19. Psychological state:      Normal                    Anxiety                   Depression            
 
 
 
Signature of the Investigator                                                   Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU NIVARANA 
CHOORANAM[INTERNAL],VATHATHIRKU THYLAM[EXTERNAL]AND 
VEDHU[EXTERNAL STHERAPY] FOR THE TREATMENT OF UTHIRA VAATHA 
SURONITHAM[RHEUMATOIDARTHRITIS]. 
FORM IV 
 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S.No:  _______2. OPD/IPD No: __________ 
3.  Name: _______________________4. Gender      : __________ 
5. Date of assessment : _____________  
SIDDHA SYSTEM OF EXAMINATION 
1.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
Kurinji   Mullai      Marutham    Neithal           Palai 
(Hilly terrain)           (Forest range)        (Plains)                  (Coastal belt)        (Arid regions)  
 
2. KAALAM: 
Kaarkalam -                     Pinpanikalam- 
Koothirkalam -                            Ilavenil - 
Munpanikalam -                          Muthuvenil - 
 
3.THEGI: 
 
4. GUNAM: 
Sathuvam   -    Rasatham -                         Thamasam  - 
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5.IMPORIGAL (SENSORY ORGANS) : 
Mei (Skin) : 
Vai (Buccal Cavity): 
Kan(Eyes) : 
Mooku(Nose): 
Sevi(Ears) : 
6.KANMENDRIYAM (MOTOR ORGANS) : 
Kai (Upper limb): 
Kaal(Lower limb): 
Vai(Buccal Cavity): 
Eruvai(Excretory organs): 
Karuvai(Reproductive organs): 
7.UYIR THATHUKKAL: 
A)VATHAM: 
Pranan: 
Abanan: 
Viyanan: 
Udhanan: 
Samanan: 
Nagan: 
Koorman: 
Kirukaran: 
Devathathan: 
Dhananjeyan: 
B)PITHAM: 
Analpitham: 
Ranjagam: 
Sathagam: 
Prasagam: 
Aalosagam: 
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C)KABAM: 
Avalambagam: 
Kilaethagam: 
Pothagam: 
Tharpagam: 
Santhigam: 
 
8.UDAL THATHUKKAL: 
Saaram[Chyme]: 
Senneer[Blood]: 
Oon[Muscle]: 
Kozhuppu[Fat]: 
Enbu[Bone]: 
Moolai[Bone Marrow]: 
Sukkilam/Suronitham 
[Genital Discharges] : 
9.ENVAGAI THERVUGAL: 
Naadi: 
Sparisam: 
Naa: 
Niram: 
Mozhi: 
Vizhi: 
Malam: 
Moothiram: 
10.NEER KURI: 
Niram: 
Manam: 
Nurai: 
Edai: 
Enjal: 
11.NEI KURI: 
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GENERAL EXAMINATION: 
Conscious level: 
Body weight: 
Height: 
BMI: 
Built: 
Nourishment: 
Temperature: 
Blood Pressure: 
Pulse rate: 
Heart rate: 
Respiratory rate: 
Anaemia: 
Jaundice: 
Clubbing: 
Cyanosis: 
Pedal oedema: 
Significant Lymphadenopathy: 
SYSTEMIC EXAMINATIONS: 
Central Nervous System: 
Cardio Vascular System: 
Respiratory System: 
Gastro Intestinal System: 
Genito Urinary System: 
EXAMINATION OF JOINTS: 
Joints Involvement : 
Morning Stiffness : 
Pain type : Recurrent attack / Episodic / Flitting or Migratory 
Inspection: 
Spinal deformities: Kyphosis/ Scoliosis/ Lordosis / None 
Swelling: 
Deformity: 
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Palpation: 
Tenderness: 
Heat: 
Fluid accumulation: 
Crepitus: 
Movements: 
 
 
CLINICAL ASSESSMENT: 
S.NO SIGNS & SYMPTOMS     BEFORE 
TREATMENT 
      AFTER 
TREATMENT 
 
1 
 
PAIN 
  
 
2 
 
SWELLING 
  
 
3 
 
REDNESS 
  
 
4 
 
TENDERNESS 
  
 
5 
 
JOINT STIFFNESS 
  
 
6 
 
JOINT DEFORMITY 
  
 
7 
LOSS OF JOINT RANGE OF 
MOTION 
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PAIN ASSESSMENT: 
UNIVERSAL PAIN ASSESSMENT SCALE 
 
A.   0    :  No Pain 
B. 1 -3  :   Mild pain 
C. 4-6  :   Moderate pain 
D. 7-10 :   Severe pain 
 Reference: Clinical Manual for Nursing Practice. (National Institute of Health Warren Grant 
Magnuson Clinical Center) 
GRADATION: 
Grade 1: Fit for all activities to do their work without support (Normal)  
Grade 2: Mild Pain and Mild restriction of Movements  
Grade 3: Moderate Pain and Moderate restriction of Movements  
Grade 4: Severe Pain and Severe restriction of Movement  
 
S.NO ASSESSMENT BEFORE 
TREATMENT 
AFTER 
TREATMENT 
1 Pain Assessment   
2 Gradation   
 
 
 
OVERALL ASSESSMENT CRITERIA OF THE STUDY  
 
 
 
 
Signature of the Investigator    Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU NIVARANA 
CHOORANAM[INTERNAL],VATHATHIRKU THYLAM[EXTERNAL]AND 
VEDHU[EXTERNAL THERAPY] FOR THE TREATMENT OF UTHIRA VAATHA 
SURONITHAM[RHEUMATOIDARTHRITIS]. 
FORM  V 
LABORATORY INVESTIGATION FORM 
 
SI.No: 
OPD/IPD No: 
Name: 
Age/Sex: 
 
I.BLOOD 
  Before Treatment After Treatment 
1 
 
TC (cells/mm)   
2 
 
DC (%)   
 a)Neutrophils  
 
 
 b)Lymphocytes  
 
 
 c)Monocytes  
 
 
 d)Eosinophils  
 
 
3 ESR(mm)   
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 a)1/2 hour  
 
 
 b)1 hour  
 
 
4 
 
Haemoglobin   
5 
 
Blood glucose   
6 
 
Blood urea/ creatinine   
7 Serum cholesterol   
 
II.URINE 
 
  
 
Before Treatment After Treatment 
1 
 
Albumin 
 
  
2 Sugar 
 
  
3 Epithelial cells 
 
  
4 Pus cells 
 
  
5 Red blood cells 
 
  
6 Casts/Crystals 
 
  
 
SPECIAL INVESTIGATION: 
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RA  FACTOR: 
 
 
Date    :       
Station : 
 
 
Signature of the Investigator    Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPUMARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF SIDDHA 
POLYHERBAL MEDICINE KEEL VAYU NIVARANA CHOORANAM[INTERNAL],VATHATHIRKU 
THYLAM [EXTERNAL]AND VEDHU[EXTERNAL THERAPY] FOR THE TREATMENT OF UTHIRA 
VAATHA SURONITHAM[RHEUMATOIDARTHRITIS]. 
FORM VI 
                                               (DRUG COMPLIANCE FORM) 
OPD/ IPD No : ____________ DOA   : ___________      
Name : _____________________ Age/Sex : ___________   S.No : _________  
Name Of The Drug : KEEL VAYU NIVARANA CHOORANAM 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
139 
 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
DATE: 
 
SIGNATURE OF THE INVESTIGATOR   SIGNATURE OF THE GUIDE/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU NIVARANA 
CHOORANAM[INTERNAL],VATHATHIRKU THYLAM [EXTERNAL]AND 
VEDHU[EXTERNAL THERAPY] FOR THE TREATMENT OF UTHIRA VAATHA 
SURONITHAM[RHEUMATOIDARTHRITIS]. 
FORM  VII 
ADVERSE DRUG REACTION FORM 
 
Name: ________________________       OPD/ IPD No : __________ 
Age: ________            Gender: ________        
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: _______________________________________________ 
________________________________________________________________________ 
 
Date: 
Station:  
 
       
 
SIGNATURE OF THE INVESTIGATOR   SIGNATURE OF THE GUIDE/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KEEL VAYU NIVARANA 
CHOORANAM[INTERNAL],VATHATHIRKU THYLAM[EXTERNAL]AND 
VEDHU[EXTERNAL THERAPY] FOR THE TREATMENT OFUTHIRA VAATHA 
SURONITHAM[RHEUMATOIDARTHRITIS]. 
 
FORM VIII 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD Number: __________ 
Age   : ________              Gender   : ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal:     YES     NO 
• Long absence in without  reporting      :     : Yes                 No 
• Irregular treatment        :                   
• Shift of locality                                                   :                   
• Increase in severity of symptoms         :                   
• Development of severe adverse drug reactions  :                   
Date    :      
Station :     
 
SIGNATURE OF THE INVESTIGATOR   SIGNATURE OF THE GUIDE/HOD 
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